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Abstract 
Dyslipidaemia is a risk factor for cardiovascular disease. Triglycerides (TG), low density 
lipoprotein (LDL) and total cholesterol (TChol) concentrations are lower in physically active 
participants and are improved by exercise training. Whether the effect of exercise on diet-
induced dyslipidaemia occurs independent of other metabolic syndrome parameters is 
nevertheless uncertain.  
The aim of the present study was to investigate the effect of exercise training on 
dyslipidaemia, induced by a high-fat-high-sucrose (HFHS) diet independent of other 
metabolic syndrome features. 48 three-month-old Sprague-Dawley rats, selected for their 
ability to run in running wheels, were fed a HFHS diet or a standard chow diet (SC) for 9 
weeks. Rats were randomly assigned to 4 groups: sedentary HFHS diet group (n=9); HFHS 
with exercise group (n=9); sedentary SC diet (n=9); and SC with exercise group (n=9). Both 
of the exercise groups were allowed to exercise voluntarily during the diet intervention. 
Fasting blood glucose (BG), insulin, glycated haemoglobin A1c (HbA1c), fasting blood 
triglyceride (TG) concentrations, body weight, daily food consumption, visceral adipose 
tissue weight, hepatic glycogen and lipid contents, liver weight, blood pressure, heart 
function and dimensions and vascular reactivity were measured. 
After 9 weeks, body weights were significantly lower in both HFHS diet groups compared to 
SC diet groups (p<0.0001) despite a greater food intake in HFHS diet groups (p<0.0001). 
BG concentrations, insulin concentration, HbA1c, normalized visceral fat tissue, hepatic lipid 
contents, normalized liver weights, heart function and dimensions, and vascular reactivity 
were not different between the groups. Fasting TG and total cholesterol concentrations were 
significantly greater with a HFHS diet compared to SC groups (p<0.0001 and p=0.029, 
respectively). HDL concentration was significantly lower with a HFHS diet compared to SC 
groups (p<0.0001) Furthermore, liver glycogen contents were significantly greater with 
HFHS diet groups compared to SC diet groups (p<0.0001). Exercise did not change the 
blood lipid concentrations and the liver glycogen contents. Systolic blood pressure, but not 
v 
 
diastolic blood pressure, was significantly higher with a HFHS diet groups compared to SC 
diet groups (p=0.021 and p=0.0573, respectively). Exercise did not change the HFHS-
induced increase in SBP. 
In conclusion, exercise does not ameliorate HFHS diet-induced dyslipidaemia and elevated 
blood pressure in adult non-obese Sprague-Dawley rats without other metabolic syndrome 
parameter changes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
Table of contents 
   Declaration .......................................................................................................................... i 
   Publications and presentations  ......................................................................................... ii 
   Acknowledgments .............................................................................................................  iii 
   Abstract ............................................................................................................................. iv 
   Table of contents .............................................................................................................. vi 
   List of figures...................................................................................................................... x 
   List of tables ...................................................................................................................... xi 
   List of abbreviations .......................................................................................................... xii 
Chapter One: Introduction ..................................................................................................... 1 
1.1 Introduction .......................................................................................................... 2 
1.2 Problem statement .............................................................................................. 3 
Chapter Two: Literature Review ............................................................................................ 6 
2.1 Western diet ........................................................................................................ 7 
2.2 The effects of high fat-high sucrose diet on metabolic parameters..................... 10 
2.2.1 Metabolism of balanced and excessive fat intake  .......................................... 10 
2.2.2 Metabolism of balanced and excessive carbohydrate intake ........................... 11 
2.2.3 The effects of high fat-high sucrose diet on metabolic syndrome characteristics 
 ................................................................................................................................ 12 
2.2.3.1 Hyperglycaemia and insulin resistance ........................................................ 13 
2.2.3.2 Obesity ........................................................................................................ 14 
2.2.3.3 Dyslipidaemia .............................................................................................. 15 
            2.2.3.4 Metabolic effects of a high fat-high sucrose diet in rats ................................ 16  
2.3 The effects of high fat-high sucrose diet on cardiovascular parameters ............. 23 
2.4  Metabolic response to an exercise intervention ................................................ 27 
2.5 The effect of exercise on cardiovascular parameters ......................................... 33 
2.6 Aims and objectives  .......................................................................................... 37 
vii 
 
Chapter Three: Materials and Methods ............................................................................... 38 
3.1 Experimental groups and exercise protocol  ...................................................... 39 
3.2 Diet compositions and preparation..................................................................... 41  
3.3 Measurements and procedures  ........................................................................ 41 
3.3.1 Blood pressure measurement ......................................................................... 41 
3.3.2 Blood measurements ...................................................................................... 42       
3.3.2.1 Fasting blood glucose and triglyceride  ........................................................ 42 
3.3.2.2 Lipid profile .................................................................................................. 42 
3.3.2.3 Haemoglobin a1c ......................................................................................... 42 
3.3.2.4 Serum insulin ............................................................................................... 42 
3.4 Echocardiography  ............................................................................................. 44 
3.5 Vascular reactivity  ............................................................................................ 46 
3.6 Organs mass  .................................................................................................... 47 
3.7 Tibial length  ...................................................................................................... 47 
3.8 Histology and aortic morphometric study ........................................................... 47 
3.9 Measurement of liver lipid and glycogen ............................................................ 47 
3.9.1 Hepatic lipid content ....................................................................................... 47 
3.9.2 Hepatic glycogen content ............................................................................... 48 
3.10 Data analysis  .................................................................................................. 50 
Chapter Four: results .......................................................................................................... 51 
4.1 The effect of short term high fat-high sucrose diet and exercise on food intake, 
body weights, visceral adipose tissue weights, kidney weights and liver weights ..... 52 
viii 
 
4.2 The effect of short-term high fat–high sucrose diet and exercise on 
Cardiovascular   parameters .................................................................................... 56 
4.2.1 The effect of short-term high fat–high sucrose diet and exercise on heart 
weights, dimensions and function as well as aortic wall thickness ........................... 56 
4.2.2 The effect of short term high fat-high sucrose diet and exercise on blood 
pressure.   ............................................................................................................... 59 
4.2.3 The effect of short term high fat-high sucrose diet and exercise on vascular 
reactivity  ................................................................................................................. 61 
4.3 The effect of short-term high fat–high sucrose diet and exercise on metabolic 
parameters .............................................................................................................. 64 
4.3.1The effect of short-term high fat–high sucrose diet and exercise on fasting blood 
glucose, haemoglobin a1c and insulin level   ........................................................... 64 
4.3.2 The effect of short term-high fat high-sucrose diet and exercise on fasting blood 
triglyceride and lipid profile ...................................................................................... 67   
4.3.3 The effect of short term- high fat high-sucrose diet and exercise on hepatic 
glycogen and lipid contents ..................................................................................... 70 
Chapter Five: Discussion .................................................................................................... 73 
5.1 The effect of High fat-high sucrose diet on body weight and tibial length  .......... 74 
5.2 The metabolic effects of high fat-high sucrose diet  ........................................... 76 
5.2.1 Blood glucose, serum insulin, glycated haemoglobin and hepatic glycogen 
contents ................................................................................................................... 76 
5.2.2 Blood lipids  .................................................................................................... 78 
5.3 The effect of high fat-high sucrose diet on cardiovascular parameters ............... 80 
5.3.1 Blood pressure ............................................................................................... 80 
ix 
 
5.4 Exercise effect on metabolic and cardiovascular parameters:  ........................... 81 
5.4.1 The effect of exercise on body weight of animals fed a High fat-high sucrose 
diet .......................................................................................................................... 81 
5.4.2 Exercise effect on blood glucose, serum insulin, glycated haemoglobin and 
hepatic glycogen content ......................................................................................... 83 
 5.4.3 Exercise and blood lipids  .............................................................................. 84 
 5.4.4 Exercise and blood pressure ......................................................................... 85 
Chapter Six: Conclusion ...................................................................................................... 87 
6.1 Conclusions ....................................................................................................... 88 
6.2 Limitations and future studies ............................................................................ 89 
6.3 Uniqueness and strength the current study ........................................................ 90 
6.4 Possible clinical implications and recommendations .......................................... 91 
 
 
 
 
 
 
 
x 
 
List of figures 
Figure 3.1: Protocol with group assignation according to dietary/exercise intervention.  ...... 40 
Figure 3.2: Measurements and procedures during the diet intervention and at termination.  43 
Figure 3.3: M-mode echocardiographic image of the left ventricle of a high fat-high 
sucrose diet fed rat ............................................................................................................ .45  
Figure 3.4: photomicrography of thoracic aortic wall section.  ............................................. 49 
Figure 4.1: Effect of short term high fat-high sucrose diet and exercise on body weights.  .. 53 
Figure 4.2: Effect of short term high fat-high sucrose and exercise on food intake.  ............ 54 
Figure 4.3: Effects of short term high fat-high sucrose diet and exercise on blood pressure. 
 ........................................................................................................................................... 60 
Figure 4.4: Effects of short term high fat-high sucrose diet and exercise on fasting blood 
glucose.  ............................................................................................................................. 65 
Figure 4.5: Effects of short term high fat-high sucrose diet and exercise on fasting blood 
triglycerides.  ....................................................................................................................... 68 
Figure 4.6: Effects of short term high fat-high sucrose diet and exercise on lipid profile.  .... 69 
 
 
 
 
 
 
 
xi 
 
List of tables 
Table 2.1:  Changes in metabolic syndrome parameters in rats consuming a high fat-high 
sucrose diet and experiencing dyslipidaemia  ..................................................................... 17 
Table 2.2: Effect of high fat-high sucrose diet in rats without obesity ................................... 20 
Table 2.3: Effect of exercise cardio-metabolic parameters in individuals with dyslipidaemia 
 ........................................................................................................................................... 29 
Table 2.4: Effect of high fat-high sucrose diet and exercise in rats ...................................... 32 
Table 4.1: Effects of dietary intervention and exercise on tibia lengths, liver weights, right 
kidney weights and visceral adipose tissue weights.  .......................................................... 55 
Table 4.2: Effects of the dietary intervention and exercise on heart weights, left ventricular 
weights and right ventricular weights.  ................................................................................. 57 
Table 4.3: Effect of short term high fat-high sucrose diet and exercise on left ventricular 
dimensions and functions as assessed in vivo .................................................................... 58 
Table 4.4: Effect of short-term high fat-high sucrose diet and exercise on vascular reactivity 
in mesenteric artery ............................................................................................................ 62 
Table 4.5: Effect of short-term high fat-high sucrose diet and exercise on vascular reactivity 
in renal artery  ..................................................................................................................... 63 
Table 4.6: Effects of short-term high fat-high sucrose diet and exercise on Hemoglobin A1c 
and insulin level.  ................................................................................................................ 66 
Table 4.7: Effects of short-term high fat-high sucrose diet and exercise on Hepatic glycogen 
contents and Hepatic lipid contents.  ................................................................................... 71 
Table 4.8: Non-normally distributed data ............................................................................. 72 
 
xii 
 
List of abbreviations 
A.Ch                   acetylcholine 
APO                   apolipoprotein (apo) 
Apo-B48            apolipoprotein B48  
BG                     llood glucose  
BP                      blood pressure 
CHD                   coronary heart diseases 
ChREBP            carbohydrate response element binding protein  
CRP                   C - reactive protein  
CVD                   cardiovascular diseases   
DASH                 dietary-approach-to stop-hypertension 
Emax                  maximum contraction response 
eNOS                 endothelial nitric oxide synthase  
EC50                  concentration of agonist at 50% maximum response 
ET-1                   endothelin-1  
FFA                    free fatty acids  
HbA1c               glycated haemoglobin  
HDL                   high density lipoprotein 
HFHS                high-fat-high-sucrose  
IDF                    International Diabetes Federation 
KCl                     potassium chloride 
LDL                   low density lipoprotein 
xiii 
 
LVEDD              left ventricular end diastolic volume  
LVESD              left ventricular end systolic diameter 
MDA                  malondialdehyde  
MG                    monoglycerides (MG) 
NAFLD               non-alcoholic fatty liver disease  
NEFA                 non-esterified fatty acid 
nfTG                   non-fasting triglycerides  
NO synthase      nitric oxide synthase 
OGTT                 oral glucose tolerance test  
Phe                    phenylephrine 
PWED                left ventricular end diastolic posterior wall thickness 
PWES                left ventricular end systolic posterior wall thickness 
RNS                   reactive nitrogen species  
ROS                   reactive oxygen species  
SD                      sprague-Dawley 
SNP                    sodium nitroprusside 
SREBBP            sterol regulator element binding protein 
TCA                  citric acid cycle 
TChol                 total cholesterol  
TG                     triglycerides 
VLDL                 very low density lipoprotein  
VPR                   volume Pressure Recording  
1 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
Chapter One: Introduction 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
2 
 
1.1 Introduction 1 
A large amount of refined carbohydrates, in addition to a large consumption of saturated fats 2 
and a high salt intake, are characteristic of a western diet (Chilton et al., 2014). According to 3 
current nutritional guidelines a high carbohydrate intake is considered to be > 45% of the 4 
total energy consumed per day and high fat to be > 30% of the total energy consumed per 5 
day (Feinman et al., 2015), while the amount of salt is considered high if it exceeds 2400 6 
mg/day (Rhee et al., 2015). The western diet is also characterized by a lack of other 7 
nutrients such as vitamins, fiber and omega 3 fatty acids (Myles et al., 2014). Consumption 8 
of a western diet in different age categories (including children) may impact on growth and 9 
may induce nutrition-related diseases (Dearth-Weasley et al., 2011; Myles et al., 2014). 10 
Indeed, over consumption of non-nutritious food with excess caloric intake are associated 11 
with various chronic diseases such as immune-mediated diseases, obesity and its related 12 
diseases, cardiovascular diseases and disturbances in cognitive ability (Myles et al., 2014). 13 
A western diet is also one of the leading causes for the metabolic syndrome (Petkevičienė et 14 
al., 2012; Boers et al., 2014; Perez-Cornago et al., 2015). The metabolic syndrome is 15 
defined by a group of metabolic and cardiovascular risk factors including insulin resistance, 16 
dyslipidaemia, hyperglycaemia, obesity and hypertension (Grundy et al., 2005). However 17 
dyslipidaemia is also an independent risk factor for cardiovascular diseases. The prevalence 18 
of both dyslipidaemia and metabolic syndrome have increased significantly in the recent 19 
years (Jameson et al., 2013; Hong et al., 2014; Pinhas-Hamiel et al., 2015; Noubiap et al., 20 
2015). In this regard current guidelines advocate lifestyle changes, including a healthy diet 21 
and physical activity as first line management for the prevention and management of life-22 
style related metabolic and cardiovascular disease risk factors (Tur et al., 2013).  23 
“Physical activity is defined as any bodily movement produced by the contraction of skeletal 24 
muscles that increases energy expenditure above resting levels and comprises of routine 25 
daily tasks such as commuting, occupational tasks, or household activities, as well as 26 
purposeful health-enhancing movements/activities” (Diaz et al., 2013, Pg.2). Physical 27 
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inactivity is a well-recognized behavioural risk factor for the development of non-1 
communicable diseases including metabolic and cardiovascular disease (Milton et al., 2015, 2 
Horodyska et al., 2015) and has consistently been associated with an increased risk of 3 
mortality independent of general adiposity (Ekelund et al., 2015). Moreover, the evidence 4 
supports that physical inactivity, characterizing the western lifestyle, is pro-inflammatory and 5 
augments oxidative stress, whereas physical activity is anti-inflammatory (Dean et al., 2012). 6 
In contrast, intervention studies have demonstrated that regular physical activity reduces 7 
morbidity and mortality associated with coronary heart disease, hypertension, diabetes, and 8 
stroke (Young et al., 2014). In this regard current research focusses on the impact of 9 
exercise and dietary interventions in obese individuals and individuals with metabolic 10 
syndrome. However, the effects of exercise on metabolic and cardiovascular risk markers 11 
while consuming a westernized diet is not certain. 12 
The current study imitated the western diet by utilizing a high fat-high sucrose (HFHS) diet 13 
model which is characterized by the concurrent inclusion of two western dietary components 14 
(saturated fat and sucrose). This study looked at the HFHS diet with and without exercise to 15 
ascertain the impact of the western diet as well as exercise on body weight, cardiovascular 16 
and metabolic parameters. 17 
 18 
1.2 Problem statement 19 
The worldwide shift in food patterns toward the consumption of a western diet has raised 20 
concerns regarding this diet (Amiri et al., 2014). The collateral rise in chronic non-21 
communicable diseases has been connected to the western diet (Chambless et al. 1997; 22 
Hariharan et al., 2015; Brigham et al., 2015). Although the direct nutritional deficit of a 23 
western diet (fiber, minerals and vitamins) plays an important part, the abundance of 24 
macronutrients is still thought to be responsible for its chronic consequences.  25 
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Recently, several epidemiological studies have documented the rise in consumption of both 1 
simple carbohydrates and saturated fat (Baker et al., 2014; Bielemann et al., 2015; de Souza 2 
et al., 2015). Previous studies have investigated the effects of only one these compositions 3 
upon metabolism and other body functions, which does not reflect the spectrum of essential 4 
components regarding the western diet. Therefore, the HFHS (both sucrose and saturated 5 
fat) diet model has been defined as the best representative model for the western diet 6 
composition and the most suitably designed model to demonstrate the impact of western diet 7 
metabolism and its subsequent effect on cardiovascular system performance.  8 
One of the chronic metabolic sequelae induced by the western diet is a high level of blood 9 
lipids, defined as dyslipidaemia. Dyslipidaemia is not only affecting older individuals but 10 
younger populations as well (Lambert et al., 2013; Wilson et al., 2015). Some of the well-11 
known consequences of dyslipidaemia include atherosclerosis, coronary heart disease, 12 
hypertension, chronic kidney diseases, pancreatitis and fatty liver diseases (Ewang-13 
Emukowhate et al., 2014; Li et al., 2014). Furthermore, dyslipidaemia has been found to 14 
affect vascular reactivity and impair the endothelial function in the coronary and forearm 15 
blood vessels of dyslipidemic individuals (Lambert et al., 2013). Dyslipidaemia may present 16 
distinctively or in association with several other disturbances including hyperglycaemia, 17 
insulin resistance, obesity, and hypertension, which are collectively known as metabolic 18 
syndrome (Grundy et al., 2005). Large epidemiological data revealed that the prevalence of 19 
metabolic syndrome in western communities has reached alarming levels and negatively 20 
impacts the active working population (Morikawa et al. 2013; Lao et al., 2014; DiBello et al., 21 
2015). 22 
Previous studies indicated that the habitual consumption of a western diet predisposes the 23 
human body to the disturbances that constitute metabolic syndrome (Saiki et al., 2007; Zhou 24 
et al., 2014). In this regard, it is crucial to identify and differentiate the contribution of a 25 
western diet for a short duration in the pathogenesis of dyslipidaemia and metabolic 26 
syndrome characteristics. Dyslipidaemia is under-diagnosed in the clinical practice and this 27 
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may be attributed to dyslipidaemia being underrated in non-obese individuals (Liao et al., 1 
2004). The present study is therefore designed to provide a better understanding of the 2 
effect of a western diet-induced dyslipidaemia independently of other metabolic syndrome 3 
features, mainly obesity. Indeed it is important to assess the impact of a western diet in 4 
inducing dyslipidaemia and its consequences in non-obese individuals. 5 
The consumption of a western diet is often associated with a sedentary lifestyle and lack of 6 
physical fitness. Physical activity in western communities has been decreasing due to long 7 
working hours and accessible transport, which makes individuals prone to a higher relative 8 
risk of cardiovascular diseases (Thijssen et al., 2010). According to current guidelines, 9 
implementing lifestyle changes could be effective in improving the metabolic parameters, as 10 
well as decreasing cardiovascular disease risk factors (Chobanian et al., 2003). In addition 11 
to being attainable and economic, exercise interventions may be the simplest in the line of 12 
management of cardiovascular disease risk factors. Previous studies have reported that 13 
lifestyle interventions including exercise and weight loss can alleviate some adverse 14 
cardiovascular and metabolic effects induced by a western diet (Golbid et al., 2012; Mohr et 15 
al., 2014; Prior et al., 2014; Beavers et al., 2014). However whether exercise can slow down 16 
or even prevent the adverse effects of a western diet independently of weight loss is not 17 
currently known. In order to institute effective therapeutic strategies, we need to determine to 18 
what extent an exercise intervention can slow the progression or prevent any cardiovascular 19 
or metabolic disturbances induced by a western diet. In particular, it is crucial to evaluate the 20 
effect of an exercise intervention on diet-induced cardiovascular risk factors including 21 
dyslipidaemia and metabolic syndrome.     22 
 23 
 24 
 25 
 26 
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This chapter focuses on a specific western diet model, a high fat-high sucrose diet (HFHS), 1 
which incorporates both saturated fat and sucrose. In this regard the metabolic and 2 
cardiovascular disturbances induced by a high fat-high sucrose diet in rats, as well as the 3 
effect of a western diet in humans, will be highlighted. Finally, this chapter briefly reviews the 4 
effect of exercise on metabolic and cardiovascular changes induced by the consumption of a 5 
western diet. 6 
 7 
2.1 Western diet  8 
Despite the characteristic abundance of a western diet in both refined carbohydrates and 9 
saturated fat, western diet models vary in the nature of these macronutrients and also in the 10 
proportions of these macronutrients (Soria et al., 2001; Novak et al., 2012; Martinez et al., 11 
2012; Tremblay et al., 2013; Panet et al., 2014; Fernando et al., 2014). Western diet models 12 
have been used for different purposes, such as to investigate the mechanisms by which the 13 
diet could predispose to a certain disease (Barnard et al., 1993; Bunnag et al., 1997; 14 
Carmiel-Haggai et al., 2005; Christon et al., 2005; Bourgoin et al., 2008), to compare the 15 
effect of different compositions in different models (Buettner et al., 2006; Boqué et al., 2009; 16 
Chun et al., 2010) or to investigate the specific effect of an interventional procedure in an 17 
already established disease by the western diet (Gonçalves et al., 2004; Arias et al., 2014; 18 
Cheng et al., 2014). Importantly, the contribution of the simultaneous inclusion of multiple 19 
macronutrients in the pathogenesis of chronic metabolic diseases is the focus of recent 20 
investigations (Mariotti et al., 2008; Lomba et al., 2010; Kabel et al., 2014). The HFHS diet 21 
has then been established to investigate the effect of a western diet on several physiological 22 
functions. The HFHS diet’s composition is formulated to reflect the proportions of 23 
macronutrients in the modern western diet. In this regard, the principal fat used in the HFHS 24 
diet is saturated animal fat (Muraki et al., 2011, Ochiai et al., 2013) or vegetable fat (Rivera 25 
et al., 2006; Paulino et al., 2010) and the carbohydrate used is sucrose.  26 
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Despite recent nutritional recommendations that the consumed amount of saturated fat 1 
should not exceed 10% of total daily energy (Weech et al., 2014), there has been a 2 
considerable increase in the consumption of saturated fat in western societies (Weech et al., 3 
2014). The current medical advice is not to decrease the fat intake, but rather change the 4 
type of fat to unsaturated fat (Benitez et al., 2015). Several studies have found that saturated 5 
fat predisposes to several diseases through its systemic inflammatory effect (Clarke et al., 6 
2009; Mu et al., 2014) and oxidative stress (Lithander et al., 2013). Saturated fat increases 7 
the risk of metabolic disturbances (Tierney et al., 2011) and of high blood pressure (Stamler 8 
et al., 1996). Indeed, a high intake of saturated fatty acids is associated with greater low 9 
density lipoprotein (LDL), total cholesterol (TChol) and triglycerides (TG) (Esser et al., 2013; 10 
Ortega et al., 2013; Virtanen et al., 2014; Benitez et al., 2015). Saturated fat negatively 11 
affects the vascular system by preventing the beneficial anti-inflammatory role of high 12 
density lipoprotein (HDL) on the endothelium (Nicholls et al., 2008) and by decreasing 13 
vascular flow mediated dilatation (Vafeiadou et al., 2015). Saturated fat is also involved in 14 
the development and the rupture of atherosclerotic plaque (Kralova et al., 2013). In contrast, 15 
the high levels of unsaturated fat (mono or poly unsaturated fat), present in the 16 
Mediterranean diet, has shown to lower blood lipids concentrations (Kralova et al., 2013), 17 
lower coronary heart disease (CHD) risk (Eschen et al., 2004; Benitez et al., 2015), to 18 
improve vascular reactivity (Newens et al., 2011) and to normalise blood pressure 19 
(Rasmussen et al., 2006). 20 
As described above, saturated fat, as a paramount component of the western diet, has 21 
devastating metabolic and cardiovascular effects. Another western diet component that is 22 
frequently associated with a negative health outcome is sucrose, a simple carbohydrate 23 
predominantly used in western food to enhance its sweet taste (Lowndes et al., 2014). 24 
Sucrose is a disaccharide carbohydrate composed of glucose and fructose, two 25 
monosaccharide molecules (Sørensen et al., 2014). Sucrose is hydrolyzed into its 26 
constituting monosaccharides by an enzyme, called sucrase, which facilitates the absorption 27 
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by the gastro-intestinal tract of both the glucose and fructose. The effects of sucrose start by 1 
the absorption of glucose, a rise in blood glucose concentration, and a subsequent increase 2 
of pancreatic insulin secretion. Additionally, over consumption of carbohydrates including 3 
sucrose, in amounts exceeding the energy requirements and the liver’s ability for glycogen 4 
deposition, induces de novo lipogenesis (Aarsland et al., 1997; Strable et al., 2010). 5 
Although de novo lipogenesis can be induced by a diet high in fat, it is mainly triggered by 6 
excess carbohydrates (Flatt et al., 19970). De novo lipogenesis converts the excessive 7 
amounts of carbohydrate into lipids, either by incorporating the excess of FFA as TG for 8 
storage or oxidizing it into energy (Strable et al., 2010). 9 
The economic affordability and worldwide availability of sucrose has contributed to 10 
maximizing its usage (Gangwisch et al., 2015). Sucrose has been recognised as being 11 
involved in the pathogenesis of several metabolic and cardiovascular diseases (Soria et al., 12 
2001; Chicco et al., 2003; Harmancy et al., 2012; Mather et al., 2001; Santure et al., 2002; 13 
Bunnag et al., 1997). Although the World Health Organisation (WHO) recommendation is to 14 
lower sugar intake to less than 10% of the total daily energy (Rugg-Gunn et al., 2007), the 15 
energy input from consumed sweeteners has risen in the last couple of decades (Lowndes 16 
et al., 2014).  17 
It is evident that the current upsurge in the consumption of both saturated fat and sucrose, 18 
that exceeds the nutritional recommendations, has deleterious side-effects. What is 19 
discussed above regarding the composition of the western diet justifies then the integration 20 
of saturated fat and sucrose (among other western diet compositions) in a representative 21 
western diet called HFHS diet. Further assessment of their excessive intake on 22 
cardiovascular and metabolic status is discussed in next section. 23 
 24 
 25 
 26 
10 
 
2.2 Effect of high fat-high sucrose diet on metabolic parameters  1 
The consumption of food loaded with saturated fat and refined carbohydrates may account 2 
for the negative impact of a western diet on metabolism (Riccio et al., 2015). Despite the fact 3 
that the end products of carbohydrates and fat metabolism may affect the body on the 4 
genetic, cellular and systemic levels (Riccio et al., 2015), this section focuses only on the 5 
systemic effects of these dietary components. 6 
 7 
2.2.1 Metabolism of balanced and excessive fat intake 8 
Dietary lipids (mostly triglycerides, TG) are absorbed in the intestine after which it is 9 
hydrolysed by the pancreatic enzymes into free fatty acids (FFA) and monoglycerides (MG). 10 
Both are combined with bile products (emulsification) to be absorbed by intestinal cells and 11 
re-synthesized into TG (Beaslas et al., 2009). TG subsequently attach to apolipoprotein in 12 
the endoplasmic reticulum of the intestinal cell to produce a chylomicron which is secreted 13 
from the intestine into the lymph and then into general circulation (Beaslas et al., 2009). 14 
Energy demanding situations, including daily activities such as exercise and fasting induce 15 
fatty acid oxidation (defined as lipolysis). The production of acetyl CoA and energy is 16 
therefore used for the ongoing vital operations in the body such as respiration, maintaining 17 
cell structure and skeletal muscles activities (Koppo et al., 2010; Frühbeck et al., 2014). The 18 
equilibrium between fat utilization and storage usually keeps TG in a low and balanced 19 
situation, whereas, the consumption of a high amount of either simple carbohydrates or 20 
saturated fats may be responsible for metabolic disturbances (Novak et al., 2012).  21 
The lipoprotein lipase induces the storage of absorbed fatty acids in adipose tissue and 22 
other tissues for later use (Goldberg et al., 1996). The inability of enzymes (involved in fatty 23 
acid oxidation and the citric acid cycle (TCA cycle) to handle the high flux of fatty acids 24 
results in less utilization of absorbed fatty acids (Bruce et al., 2009). Overfeeding of a diet 25 
composed of a high amount of fat induces less oxidation of the absorbed fatty acids and 26 
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more storage (Horton et al., 1995, Gibson et al., 2007). In healthy individuals, ingestion of a 1 
diet rich in fat results in greater concentrations in LDL and TChol compared to the 2 
consumption of a low fat diet (Tremblay et al., 2013). Consuming a diet high in fat, even for a 3 
short period of time, also leads to an increase in plasma FFA in sedentary individuals 4 
(Edwards et al., 2010). Hence, a lack of balance between the dietary intake of fatty acid and 5 
its processing induces an increased lipid accumulation in different organs which may result 6 
in further metabolic disturbances such as impaired insulin secretion (Man et al., 1997), 7 
lipotoxicity in heart muscles (Turkieh et al., 2014) and the expansion of visceral adipose 8 
tissue (Lyer et al., 2012; Novak et al., 2012). Finally, non-alcoholic fatty liver diseases, non-9 
alcoholic steatohepatitis, as well as renal injury and proteinuria through obesity related-10 
glomerulopathy, are ultimate consequences induced by a diet rich in fat and the subsequent 11 
elevated plasma FFA concentration (Pan et al., 2014). 12 
 13 
2.2.2 Metabolism of balanced and excessive carbohydrate intake 14 
Dietary carbohydrates are absorbed in the small intestine and hydrolysed by enzymes into 15 
simple carbohydrates (Sørensen et al., 2014). Sucrose is hydrolysed by sucrase into 16 
glucose and fructose (Sørensen et al., 2014). In turn, the resultant simple carbohydrates are 17 
oxidized by cellular mitochondria into pyruvate (Flatt et al., 19970). Pyruvate is then oxidized 18 
into acetyl CoA and by-product energy as adenosine triphosphate (ATP) (Aarsland et al., 19 
1997). In this way, the metabolised carbohydrate produces energy for basic use in the cells 20 
and maintains the energy balance. 21 
The surplus glucose from the metabolised excess carbohydrate will be stored as glycogen in 22 
the liver (in a limited capacity) and in the skeletal muscles under the effect of insulin (Bollen 23 
et al., 1998; Randle et al., 1999). Further exuberant glucose above the body’s limited 24 
capacity to store glycogen, is directed for de novo lipogenesis (Schwarz et al., 1995; Kersten 25 
et al., 2001; Ferré et al., 2010). Furthermore, insulin stimulates the transcriptional factors 26 
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sterol regulator element binding proteins (SREBP) and the high blood glucose level induces 1 
carbohydrate response element binding protein (ChREBP) which are both responsible 2 
transcriptional factors in the upregulation of fat synthesis (Osei-Hyiaman et al., 2008). 3 
Insulin, released by high blood glucose following high sucrose intake, induces the activation 4 
of hepatic fatty acid synthase which is one of the main enzymes in the de novo lipogenesis 5 
(Flatt et al., 19970). The excess glucose oxidation results in the accumulation of acetyl CoA. 6 
This accumulated acetyl CoA forms the main substrate for de novo lipogeesis and the 7 
formation of fatty acids which are released from the liver as triacylglycerol fatty acids (TGFA) 8 
and very low density lipoprotein (VLDL) (Schonfeld et al., 1971). The high release of 9 
secreted VLDL in the blood causes an increase in blood lipids and may be responsible for 10 
the development of dyslipidaemia (Schonfeld et al., 1971). Additionally, the excessive 11 
amount of absorbed fructose causes the dysregulation of hepatic metabolism by directing 12 
the resultant carbon into de novo lipogenesis and further accumulation of lipids in the blood 13 
(Basciano et al., 2005; Merino-Aguilar et al., 2014).  14 
 15 
2.2.3 The effect of a high fat-high sucrose diet on metabolic syndrome characteristics 16 
Metabolic syndrome is a cluster of cardiovascular and metabolic disease risk factors 17 
including abdominal obesity, insulin resistance, elevated blood pressure, atherogenic 18 
dyslipidaemia, pro-thrombotic state and a pro-inflammatory state (Grundy et al., 2005). 19 
Different criteria have been proposed for the diagnosis of metabolic syndrome in humans. 20 
The WHO requires a marker of insulin resistance and an additional two risk factors of the 21 
previously mentioned risk factors. The International Diabetes Federation (IDF) requires 22 
obesity as the main cornerstone for the diagnosis of metabolic syndrome in addition to a 23 
further two risk factors (Grundy et al., 2005). However in rats, consumption of a HFHS diet 24 
may induce metabolic syndrome or most of the risk factors constituting metabolic syndrome 25 
(Barnard et al., 1993; Yamamoto et al., 2006; Pranprawit et al., 2013). The concurrent 26 
consumption of large amounts of both sucrose and saturated fat by rats has been shown to 27 
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induce more profound metabolic disturbances than the consumption of a high sucrose or a 1 
high fat diet alone (Osabe et al., 2008; Ragab et al., 2015). Most of the metabolic syndrome 2 
characteristics are interrelated and can be induced by consumption of a HFHS diet. 3 
 4 
2.2.3.1 Hyperglycaemia and insulin resistance 5 
Blood glucose concentration is marked by the equilibrium between glucose uptake and 6 
glucose metabolism (Harber et al., 2005). The abnormally high blood glucose is defined as 7 
hyperglycaemia (Matsui et al., 2012). Hyperglycaemia has been reported previously in 8 
animal studies with different models of the western diet )Matsui et al., 2012; Martinez et al., 9 
2012; Fernando et al., 2014). Although not all animal studies observed a change in blood 10 
glucose concentration with the HFHS diet (Ivanova et al., 2011; Medford et al., 2012) rats 11 
consuming the HFHS diet may develop hyperglycaemia (Sugatani et al., 2006; La Favor et 12 
al., 2013; Zhou et al., 2014; Zhang et al., 2015). An increased serum insulin concentration 13 
and insulin resistance have been also observed in rats fed the HFHS diet (Chun et al., 2010; 14 
Pierine et al., 2014; Cheng et al., 2014; Méndez et al., 2014; de la Garza et al., 2015). In 15 
contrast, other studies have reported no change in insulin levels (Ivanova et al, 2011; Fisher-16 
Wellman et al., 2013; La Favor et al., 2013). Hyperglycaemia is a recognized feature of 17 
insulin resistance. A majority of the studies have reported a concurrent elevated blood 18 
glucose level with an increased insulin concentration (Sugatani et al., 2006; Zhou et al., 19 
2014; Zhang et al., 2015). However, some studies have still reported no change in insulin 20 
concentration despite the elevated blood glucose concentration (Fisher-Wellman et al., 21 
2013; La Favor et al. 2013). It is possible that, in these studies, the rats may not have 22 
developed insulin resistance yet. However, this could also be due to the effect of the short 23 
duration of the studies on both the glucose and insulin levels. Nevertheless, as discussed 24 
above, there is still controversy about whether a HFHS diet will result in insulin resistance 25 
and an elevated blood glucose level. 26 
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2.2.3.2 Obesity 1 
Despite the role of a genetic predisposition, obesity is mainly attributed to high energy 2 
consumption or/and low energy expenditure which might be due to low activity (Roberts et 3 
al., 2002). An acknowledged dietary factor which influences visceral adiposity is the 4 
saturated fat content of the food (Sun et al., 2013), while the carbohydrate content of food is 5 
the main contributor to weigh t gain (Westman et al., 2007; Hession et al., 2009; Hite et al., 6 
2010). Thus, obesity is a frequent consequence of the consumption of a western diet (Pratt 7 
et al., 2010; la Fleur et al., 2010; Uriarte et al., 2013; Pierine et al., 2014) and hence a 8 
cornerstone of the development of metabolic syndrome. Obesity is associated with a high 9 
incidence of chronic metabolic diseases including diabetes mellitus, dyslipidaemia, non-10 
alcoholic liver disease and chronic kidney diseases (Kamimura et al., 2013; Noborisak et al., 11 
2013; Belczak et al., 2014; Huetter et al., 2014). Insulin resistance, associated with obesity, 12 
may be the main contributor to the pathogenesis of these chronic diseases (Pierine et al., 13 
2014). Increased visceral fat mass (characterizing obesity) induces inflammatory, oxidative 14 
and metabolic changes (Pierine et al., 2014). Beta-cell dysfunction and the subsequent 15 
abnormal insulin secretion, as well as inability to regulate the glucose level, are associated 16 
with obesity (Zhang et al., 2001). The accumulated adipose tissue also plays an essential 17 
role in insulin resistance through increasing the release of FFA which induces muscle to 18 
resist insulin action through impairing the insulin signalling pathway (Kelley et al., 2001; 19 
Jellinger et al., 2007). It is also well known that obesity is characterised by inflammation, 20 
which may result in insulin resistance (Pradhan et al., 2007). 21 
In addition to insulin resistance, obesity has been found to be associated with abnormal 22 
glucose metabolism, glucose intolerance and hyperglycaemia (Pozzan et al., 1997; 23 
Edelstein et al., 1997; Stolk et al., 1997). Impaired glucose tolerance, as a phase of glucose 24 
intolerance, indicates a high risk for development of diabetes (Tuomilehto et al., 2001). 25 
Insulin resistance in individuals with a high body mass index (BMI) is more likely to progress 26 
to diabetes mellitus (Resnick et al., 1998; Matsumoto et al., 2001). Furthermore, high fasting 27 
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blood glucose in obesity indicates a higher than normal incidence of progression to diabetes 1 
(Edelstein et al., 1997; Tuomilehto et al., 2001). Chronic hyperglycaemia is known to be 2 
associated with increased protein kinase C and several biochemical pathways like protein 3 
glycation, polyol and glucose autoxidation (de Carvalho et al., 2012). These pathways 4 
subsequently increase the oxidative stress (de Carvalho et al., 2012). 5 
 6 
2.2.3.3 Dyslipidaemia 7 
Another metabolic syndrome feature resulting from the HFHS diet is dyslipidaemia (Sugatani 8 
et al., 2008; Bourgoin et al., 2008; Pranprawit et al., 2013; Zhou et al., 2014; Kabel et al., 9 
2014). Dyslipidaemia is a metabolic disturbance defined by high concentrations of TChol, TG 10 
and LDL, in addition to a low HDL level (Nelson et al., 2013). Dyslipidaemia is also marked 11 
by the ratio of TChol to HDL, as it integrates information about LDL and TG (Wietlisbach et 12 
al., 2013). Dyslipidaemia can be classified as primary (genetic defect) or secondary 13 
(environmental causes) (Nelson et al., 2013; Teramoto et al., 2014). In both primary and 14 
secondary dyslipidaemia, despite the genetic susceptibility in primary dyslipidaemia, diet is 15 
still a strong predisposing environmental factor (Teramoto et al., 2014). Nevertheless, the 16 
main factor responsible for secondary dyslipidaemia is a diet rich in saturated fat and high in 17 
sugar (Bourgoin et al., 2008; Kabel et al., 2014; Zhou et al., 2014). A HFHS diet induces an 18 
increase in production and a decrease in clearance of blood lipids (Robert et al., 2004). A 19 
defect in lipoprotein lipase functioning and a decreased expression of VLDL and LDL 20 
receptors are the main contributors to the raised blood lipids concentration (Robert et al., 21 
2002). In addition, impaired hepatic catabolism of cholesterol and abnormal hepatic enzyme 22 
activities are also responsible for the development of dyslipidaemia (Robert et al., 2004; 23 
Kabel et al., 2015). Moreover, hyperglycaemia and insulin resistance have also been 24 
associated with dyslipidaemia (Chicco et al., 2003; Harmancey et al., 2012) and elevated 25 
level of TG in the blood, in the liver as well as in the muscle (Ochiai et al., 2013). Indeed, 26 
insulin resistance affects apoprotein production and the regulation of lipoprotein lipase in the 27 
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liver which may predispose to dyslipidaemia in association to hyperglycaemia (Goldberg et 1 
al., 2001).  2 
 3 
2.2.3.4 Metabolic effects of a high fat-high sucrose diet in rats 4 
Despite the evidence of altered metabolic status due to a western diet in humans, a number 5 
of studies have investigated these effects in animals. A summary of the animal studies 6 
assessing the effect of a HFHS diet on metabolic syndrome parameters in rats experiencing 7 
dyslipidaemia are provided in Table 2.1. In this table, the various studies sued diets that 8 
were composed of sucrose between 20 and 65% and between 20 and 77% fat. Different rat 9 
species had been used including Sprague-Dawley, Wistar, Hanover and Fischer rats. The 10 
age of the animals varied between 4 weeks and 4 months (Sugatani et al., 2008; Ochiai et 11 
al., 2013; Zhang et al. 2015). The studies lasted between 3 weeks and 22 months with the 12 
most pronounced metabolic responses noted over the longer duration (Saiki et al., 2007; 13 
Zhou et al., 2014) and with higher carbohydrate content (Bourgoin et al., 2008; Sun et al., 14 
2013; Pranprawit et al., 2013; Zhou et al., 2014). 15 
In most of these studies, the HFHS diet-induced dyslipidaemia is associated with a 16 
concomitant increase in glucose concentration and secretion of insulin (Bourgoin et al., 17 
2008; Sugatani et al., 2008; Pranprawit et al., 2013; Ochiai et al., 2013; Sun et al., 2013; 18 
Zhou et al., 2014; Kabel et al., 2014; Zhang et al., 2015). This may be attributed to the 19 
decompensation of pancreatic beta-cells. However, no changes in blood glucose 20 
concentration and plasma insulin concentration were observed in one study (Ivanova et al., 21 
2011), which could be attributed to the beta-cell of the pancreases compensating with an 22 
increase in mass to maintain normoglycemia. According to table 2.1, dyslipidaemia may also 23 
be seen in conjunction with either obesity (Roberts et al., 2004; Bourgoin et al., 2008; 24 
Yamamoto et al., 2010; Pranprawit et al., 2013; Sun et al., 2013; Kabel et al., 2014) or 25 
without obesity (Roberts et al., 2002 ; Saiki et al., 2007; Sugatani et al., 2008; 26 
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Table 2.1: Changes in metabolic syndrome parameters in rats consuming high fat-high sucrose diet and experiencing dyslipidaemia 
Article Strain Age/B.wt Diet composition Duration 
Blood 
lipids 
Blood 
glucose 
Insulin B.wt Bp 
Zhang et al., 
2015 
Male Wistar 6 weeks 
20% protein, 34% 
starch, 15% sucrose, 
20% fat 
8 weeks    -- ## 
Kabel et al., 
2014 
Wistar 100–150 g 
fat emulsion (77% fat, 
14% protein, 9% 
starch) +18% sucrose 
solution 
8 weeks     ## 
Zhou et al., 
2014 
Sprague-
Dawley 
200–250 g 
65% sucrose, 25% 
fat, 10% protein 
48 weeks     ## 
Ochiai et al., 
2013 
Male Wistar 4 weeks 
30% protein, 20% 
sucrose, 14.8 % 
starch, 25% fat 
8 weeks    -- ## 
Pranprawit et 
al., 2013 
Sprague- 
Dawley 
9 weeks 
19.6% protein, 40% 
fat, 41% sucrose 
4 weeks or 
8 weeks 
    ## 
Sun et al., 2013 
Sprague- 
Dawley 
180–220 g 
16.89% protein, 
39.39% fat, 43.7% 
sucrose 
8 weeks     ## 
Ivanova et al. 
2011 
Male Wistar 12 weeks 
34.7% fat, 30% 
sucrose 
48 days  -- -- -- ## 
Yamamoto et 
al., 2010 
Male 
Sprague-
Dawley 
7 weeks 
15.5% fat, 40 % 
sucrose, 20.5% 
protein 
4 weeks  ## ##   
Bourgoin et al., 
2008 
Male 
Sprague- 
Dawley 
6 weeks 
21% protein, 39% fat, 
41 % sucrose 
4 weeks  
 
unfasted 
   
Sugatani et al., 
2008 
Male Wistar 6 weeks 
23.9% fat, 56.8% 
sucrose, 19.3% 
protein 
3 weeks    -- ## 
Mariotti et al. 
2008 
Wistar–
Hanover 
130-140 g 
19.25 % protein, 
14.5% fat, 48.7% 
9 weeks ↑ ↑ ↑ -- ## 
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male sucrose 
Saiki et al., 
2007 
Male 
Sprague-
Dawley, 
female 
Wistar 
Kyoto 
4 months 
23.4% protein, 11.0% 
fat, 6.3% starch, 15% 
sucrose solution 
12 months ↑ ↑ ↑ -- ## 
Roberts et al., 
2004 
Female 
Fischer 
2 months 40% sucrose, 39% fat 20 months  ## ##   
Roberts et al., 
2002 
Female 
Fisher 
2 months 40% sucrose, 39% fat 22 months  ## ## --  
(↑) increased, (↓) decrease, (--) No change, (≠≠) not measured. B.wt, Body weight; Bp, Blood pressure.
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Mariotti et al., 2008; Ivanova et al., 2011; Zhang et al., 2015). Hence, these studies suggest 
that a HFHS diet is one of the causes that predispose to dyslipidaemia and may be 
associated with other metabolic syndrome disturbances. However, the mechanism by which 
concomitant occurrence of dyslipidaemia and the other metabolic defects occur is still not 
clear. Furthermore, what is the effect of a HFHS diet on the metabolic status in absence of 
obesity? The relevant animal studies showing the metabolic impact of a HFHS diet without 
inducing obesity are summarised in Table 2.2. In these studies, the diets were composed of 
between 20 and 48% sucrose and 10 and 62% fat and lasted from 3 weeks up to 22 months. 
The rat species included Sprague-Dawley, Wistar, Hanover and Fischer rats and their ages 
varied between 4 weeks and 4 months with younger rats more resistant to obesity (Medford 
et al., 2012; La Favor et al. 2013; Fisher-Wellman et al., 2013). Insulin levels were greater in 
Wistar rats (Sugatani et al., 2008; Ochiai et al., 2013; Etxeberria et al., 2013; Arias et al., 
2014; Zhang et al., 2015). Longer studies showed that greater glucose concentration (Robert 
et al., 2002; Souza et al., 2007; Saiki et al., 2007) and dyslipidaemia is noted with high 
carbohydrate content (Sugatani et al., 2008; Mariotti et al., 2008; Zhang et al., 2015). 
From the table, it is shown that the non-obese animals consuming a western diet still 
showed considerable metabolic side effects. A few of these studies showed that non-obese 
animals (animals that did not gain a significant amount of weight) consuming the HFHS diet 
experienced hyperglycaemia (Saiki et al., 2007; Souza et al., 2007; Mariotti et al., 2008; 
Ochiai et al., 2013; Fisher-Wellman et al., 2013; Etxeberria et al., 2013; Arias et al, 2014). 
Most of the studies with an increased glucose concentration, report a simultaneous elevated 
insulin concentration (Saiki et al., 2007; Mariotti et al., 2008; Etxeberria et al., 2013; Ochiai et 
al., 2013; Arias et al., 2014). This suggests that hyperglycaemia and insulin resistance 
induced by a western diet may be present without obesity. It is also interesting to note that 
no change in glucose levels (Ivanova et al., 2011; Medford et al., 2012) or a glucose level 
lower than the control group (which may be the result of liver disease) (Hirotani et al., 2012) 
has also been reported in a rats fed a HFHS diet without obesity. Similarly, several studies in 
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Table 2.2: Effect of high fat-high sucrose diet in rats without obesity 
Article Strain Age/B.wt. Diet composition Duration 
Blood 
glucose 
Insulin 
Blood 
lipids 
Others 
Zhang et 
al., 2015 
Male 
Wistar 
6 weeks 
20% protein, 34% 
starch, 15% 
sucrose, 20% fat 
8 weeks     
Arias et a.l, 
2014 
male 
Wistar 
6 weeks 
22.5% fat, 20% 
sucrose  
6 weeks.   ## 
No difference in free fatty 
acids 
Ochiai et 
al., 2013 
male 
Wistar 
4 weeks 
30% protein, 20% 
sucrose, 14.8 % 
starch, 25% fat 
8 weeks  
after 
OGTT 
TChol 
--TG 
Adiponectin, liver TG, 
Lpl activity 
Fisher-
Wellman et 
al., 2013 
Male 
Sprague-
Dawley 
5 weeks 
14.8% protein, 
44.6% fat, 34 % 
sucrose, 6.2% 
starch 
12 weeks  -- -- 
↓mitochondrial H2O2 in 
heart, ↑in RG 
Etxeberria 
et al., 2013 
Male 
Wistar 
12 weeks 
20% proteins, 
35% sucrose, 
45% fat 
63 days   ## 
Hyperleptinemia, no 
difference in serum total 
protein, ↓serum urea 
Hirotani et 
al., 2012 
Male 
Wistar 
180-190 g 
23% protein, 
25.3% sucrose, 
35% fat 
12 weeks 
Lower than 
control 
## 
TG TChol 
lower than 
control 
↑liver weight, ↑AST, non-
alcoholic fatty liver disease 
La Favor et 
al., 2013 
male 
Sprague-
Dawley 
5, 9 &13 
weeks 
34% sucrose, 6% 
starch, 23% fat, 
17.3% protein. 
12weeks ↑ -- -- Vascular reactivity changes 
Medford et 
al., 2012 
Male 
Sprague-
Dawley 
4 weeks 
40% fat, 15% 
protein, 31% 
sucrose, 14% 
starch 
52 weeks -- ## 
-- TG- 
TChol 
↑HbA1c, lower  indices of 
renal function, no different 
in (tibia length, liver& 
kidney weight) 
Ivanova et 
al., 2011 
Male 
Wistar 
12 weeks 
34% fat, 30% 
sucrose 
48 days -- -- 
↑(TG,LDL, 
VLDL) 
No difference in heart 
weight and systolic BP,↓ 
collagen I and III  in LV 
Sugatani et 
al., 2008 
Male 
Wistar 
6 weeks 
23.9% fat, 56.8% 
sucrose, 19.3% 
protein 
3 weeks     
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Roberts et 
al., 2002 
Female 
Fisher 
2 months 
40% sucrose, 
39% fat 
22 months  ## ## Increased BP 
Mariotti et 
al., 2008 
Wistar– 
Male 
Hanover  
130-140 g 
19.25 % protein, 
14.5% fat, 48.7% 
sucrose 
9 weeks ↑ ↑ 
↑TAG↑HDL, 
↓ T.Chol 
↓blood glutathione. No 
change in blood pressure 
Saiki et al., 
2007 
Male 
Sprague-
Dawley, 
female 
Wistar 
Kyoto 
4 months 
23.4% protein, 
11.0% fat, 6.3% 
starch, 15% 
sucrose solution 
12 months ↑ ↑ ↑TChol 
↑liver (cholesterol, TG, 
relative weight), ↑plasma 
ALT, oxidative stress and 
↑lipid peroxide 
Souza et 
al., 2007 
Wistar 60-day 
25% sucrose, 
23% starch, 25% 
protein, 10% fat 
4 months ↑ by GTT ## ## 
(Altered insulin sensitivity), 
↑ Protein oxidation in 
frontal cortex 
Rivera et 
al., 2006 
Male 
Wistar 
300–325 g 
32% fat, 48% 
sucrose, 20% 
protein 
6 weeks ## -- ## 
No difference in leukocyte 
number in blood, 
Occasional cytoplasmic 
lipid accumulation in liver 
Grimditch et 
al., 1987 
Female 
Sprague-
Dawley 
125-150g 
21% protein, 40% 
fat, 39 % sucrose 
10-12 
weeks 
--by IVGTT ↑ ## 
No different in sarcolemmal 
vesicles orientation 
(↑) increased, (↓) decrease, (--) No change, (≠≠) not measured. B.Wt, Body weight; BP, Blood pressure, HbA1c, LPL, lipoprotein lipas
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rats have not reported a change in insulin concentration (Riviera et al., 2006; Ivanova et al., 
2011; Medford et al., 2012). To note, one study showed an increased in insulin concentration 
without a change in blood glucose concentration (Grimditch et al., 1987). From these studies 
we can conclude that the simultaneous occurrence of a high insulin level and 
hyperglycaemia (in the absence of obesity) can be attributed to the strain and the age of the 
rats or the duration and the composition of the diet. However, it is not clear what the main 
metabolic defect is that contributes to these changes.  
A HFHS diet may induce dyslipidaemia with an absence of obesity (Saiki et al., 2007; 
Mariotti et al., 2008; Ivanova et al., 2011; Ochiai et al., 2013). A HFHS diet induces 
metabolic abnormalities such as lipid accumulation in the liver and abnormal liver enzymes 
(Ochiai et al., 2013; Saiki et al., 2007). A HFHS diet in non-obese animals has been shown 
to induce decreased activity of lipoprotein lipase and adiponectin, an enzyme and hormone 
responsible for blood lipid processing (Ochiai et al., 2013). Another noticeable consequence 
of consuming a HFHS diet in the absence of obesity is the increase of adipose tissue 
(Ivanova et al., 2011; Fisher-Wellman et al., 2013). Adipose tissue may secrete substances 
affecting lipid metabolism (Ivanova et al., 2011; Fisher-Wellman et al., 2013). In this respect, 
adipocytes are well known to produce adipo(cyto)kines and other inflammatory substances 
(Zhou et al., 2014), as well as an elevation of reactive oxygen species (ROS) and reactive 
nitrogen species (RNS) which, subsequently, can affect lipid metabolism (Boqué et al., 
2009). On the other hand, some studies did not report dyslipidaemia with a HFHS diet in the 
absence of obesity (Medford et al., 2012; Etxeberria et al., 2013; Fisher-Wellman et al., 
2013; La Favor et al. 2013). An increase in the activity of leptin, an adipo(cyto)kine secreted 
by adipose tissue and responsible for energy equilibrium, may explain the absence of 
dyslipidaemia and obesity with a HFHS diet (Etxeberria et al., 2013).  
The above discussion highlights that a HFHS diet, as the model for a western diet, can 
induce considerable metabolic disturbances. Furthermore, the evidence from this discussion 
shows that controversy still exists over the occurrence of simultaneous metabolic changes 
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associated with dyslipidaemia in the absence of obesity. Mainly, it is not clear whether 
dyslipidaemia induced by a HFHS diet is associated with other metabolic syndrome defects 
without obesity. Therefore, it is crucial to illuminate the role of a HFHS diet in the 
development of dyslipidaemia with or without metabolic syndrome characteristics in animals 
which present no obesity. 
 
2.3 The effect of a high fat-high sucrose diet on cardiovascular parameters  
An important system affected by the consumption of a western diet is the cardiovascular 
system. The different components of the western diet, namely high saturated fat and high 
sucrose, affect the cardiovascular system in different ways. Among several causes, one 
factor thought to increase the prevalence and to further exacerbate cardiovascular diseases 
is the unhealthy composition of the western diet (Robert et al., 2004; Baumann et al., 2015). 
Although lifestyle intervention and dietary intervention are considered first line therapy in the 
management of cardiovascular disease (Folsom et al., 2015; Masset et al., 2015), it remains 
important to ascertain to what extent the western diet predisposes or initiates the cardio-
metabolic risk factors and to determine whether HFHS diet in absence of obesity may induce 
dyslipidaemia and other metabolic syndrome features.  
Clinical trials have shown that cardiac and metabolic risk factors are linked. For instance, a 
HFHS diet predispose to dyslipidaemia (Sugatani et al., 2008; Bourgoin et al., 2008; 
Pranprawit et al., 2013; Zhou et al., 2014; Kabel et al., 2014), which is associated with 
numerous cardiovascular risk factors including high blood pressure and atherosclerosis 
(Barnard et al., 1998; Yamamoto et al., 2006). Furthermore hypertension, one of the leading 
risk factors for cardiovascular disease, is strongly associated with obesity, insulin resistance 
and uncontrolled diabetes (Roca et al., 2005). Despite the fact that cardiovascular disease 
risk factors in relation to metabolic syndrome has been widely investigated, and despite the 
considerable effect of a western diet in inducing cardiovascular diseases, the mechanism by 
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which a western diet predisposes to simultaneous multiple cardiovascular risk factors is still 
not clear and needs to be elaborated. In this regard, a HFHS diet has been shown to induce 
considerable cardiovascular disturbances, including an increase in cardiac output (Seymour 
et al., 2015), raised atherogenic index (Kabel et al., 2014), predisposing to oxidative stress 
(Lomba et al., 2010; Fisher-Wellman et al., 2014), inducing vascular dysfunction (Bourgoin 
et al., 2008; La Favor et al., 2013), and increased blood pressure (Barnard et al., 1993; 
Robert et al., 2001; Bourgoin et al., 2008; Yamamoto et al., 2006; Xie et al., 2013; Kong et 
al., 2014).  
One of the major risk factors of cardiovascular disease is hypertension. Substituting a HFHS 
diet with a diet low in fat and high in complex carbohydrates reversed the elevated blood 
pressure, which emphasises the impact of a HSFS diet on blood pressure elevation (Roberts 
et al., 2002). Moreover, in a dietary-approach-to-stop-hypertension (DASH) clinical trial, 
following a diet high in fat with a healthy diet intervention led to a lowering of blood pressure 
(Appel et al., 1997). In this regard, DASH study enrolled 459 individuals whose blood 
pressure less than160/95 mmHg. The participants received a diet high in fruit, vegetable and 
low-fat dairy product and low in saturated fat (Appel et al., 1997). This diet intervention last 
for 8 weeks. Furthermore, several animal studies have shown the impact of a HFHS diet in 
the development of hypertension. The elevation of blood pressure has been reported in a 
longer duration (20 to 24 months) studies (Barnard et al., 1993; Robert et al., 2001; Kong et 
al., 2014) but also in a shorter duration (3 to 4 weeks) diet intervention with a HFHS diet 
(Yamamoto et al., 2006; Bourgoin et al., 2008). Dyslipidaemia and endothelial dysfunction 
have been found to be responsible for elevated blood pressure following consumption of a 
HFHS diet (Bourgoin et al., 2008). Dyslipidaemia and endothelial dysfunction are, however, 
not the only recognized factors in inducing the elevation of blood pressure. A HFHS diet has 
been found to predispose to renal injury and glomerulopathy (Kong et al., 2011) as well as 
oxidative stress through enhancing dietary lipid peroxidation (Roberts et al., 2002) in addition 
to increasing inflammatory markers which all predispose to elevate blood pressure (Robert 
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et al., 2005; Pierine et al., 2014). Furthermore, a HFHS diet causes atherosclerosis (Munshi 
et al., 2014). Inflammation is known to be involved in the pathogenesis of atherosclerosis 
(Koizumi et al., 2013).  
Although metabolic syndrome is associated with the risk of developing cardiovascular 
disease, obesity is associated with the development of cardiovascular disease (Klein et al., 
2004). First, there is evidence to support that obesity may be a major contributor to the 
development of hypertension (Harris et al., 2000). In this regard, obesity induces vascular 
dysfunction which results from abnormal vasomotor tone, enhanced vasoconstriction and 
decreased vasodilatation (Steinberg et al., 1996). Vascular dysfunction associated with 
obesity may be mediated by a decreased Nitric Oxide synthase (NOS) activity (Walther et 
al., 2015). Vascular abnormalities related to obesity are associated with inflammation and 
oxidative stress, which leads to endothelial dysfunction and decreased nitric oxide 
bioavailability (Steinberg et al., 1996). In addition, obesity causes an increased activation of 
the renin-angiotensin-aldosterone system, ultimately resulting in an elevated blood pressure 
(Hajer et al., 2008). Furthermore, obesity induces micro and macro vascular dysfunction. 
Obesity leads to anatomical vascular changes, such as an increased wall to lumen ratio and 
the microvascular rarefaction (a decrease in the number of arterioles or capillaries) of 
various tissues, which contributes to an increased blood pressure (Serné et al., 2007). 
Obesity is associated with increased plasma FFA concentration (Brotman et al., 2002). This 
vascular impairment is believed to be mediated through FFA and inflammatory mediators 
released from the adipose tissue (de Jongh et al., 2004). Table 2.2 summarises studies of 
the HFHS model without obesity. HFHS without obesity is still able to induce the impairment 
of vascular reactivity (La Favor et al., 2013) and cause oxidative stress (Saiki et al., 2007). 
Other changes in the hearts of rats consuming the HFHS diet (lower collagen I and collagen 
III in the ventricular tissue) were noticed (Ivanova et al., 2011). Finally, a HFHS diet 
intervention did not elevate the blood pressure in rats without obesity (Mariotti et al., 2008; 
Ivanova et al., 2011). However one study reported an increase in blood pressure in the 
26 
 
absence of obesity (Roberts et al., 2002). The discrepancy may be attributed to the different 
responses from different rat species. While the studies that reported an increase of blood 
pressure used Sprague-Dawley and Fischer rats, the ones that did not report an increase of 
blood pressure used Wistar rats. 
Dyslipidaemia is a well-recognized risk factor for coronary heart disease (CHD) (Fattore et 
al., 2014). Although a low level of HDL is an independent risk factor for anticipating 
cardiovascular events (Ono et al., 2012), LDL plays the most important part in the 
atherogenicity of blood lipids (Chan et al., 2006; Jia et al., 2008). Table 2.1 highlights the 
studies for rats affected with dyslipidaemia following consumption of a HFHS diet. Even 
though not all of the studies in tables 2.1 measured blood pressure or assess cardiovascular 
function, dyslipidaemia has been shown to be associated with changes in heart and vascular 
functions. Three studies reported an increase in blood pressure accompanied with 
dyslipidaemia in obese rats (Roberts et al., 2004; Bourgoin et al., 2008; Yamamoto et al., 
2010). Dyslipidaemia in obese rats has been reported simultaneously with a high 
atherogenic index, as well as an increased insulin level or a raised C-reactive protein (CRP) 
concentration (Robert et al., 2004). These are all cardio-metabolic risk factors. Animals 
consuming a HFHS diet, but without inducing obesity, exhibit also some adverse effects on 
the heart and the vasculature as well (Saiki et al., 2007; Ivanova et al., 2011; Ochiai et al., 
2013).  
From the aforementioned investigations, it is clear that consuming a HFHS diet and obesity 
both have profound negative impacts on cardiovascular performance. Nevertheless, it has 
been shown that a HFHS diet is still able to induce cardiovascular disturbances without 
obesity. Despite the abundant information on the western diet effect, the mechanism by 
which a HFHS diet could predispose to cardiovascular disturbances in the absence of 
obesity is still not clear. Furthermore, we need to illuminate more on the mechanism by 
which a western diet induces development of concurrent cardiovascular risk factors in the 
absence of the obesity. 
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2.4 Metabolic response to an exercise intervention 
The metabolic effect of various exercise training regimens has been widely investigated in 
different population groups, including healthy persons (Schneider et al., 2009; Oberbach et 
al., 2010; Stepto et al., 2012; Heinonen et al., 2012) and persons with obesity (Coker et al., 
2006; Bocalini et al., 2012; Khadir et al., 2015), diabetes mellitus (Yavari et al., 2010; 
Kadoglou et al., 2013; Motahari-Tabari et al., 2014; Lowenstein et al., 2014; Kluding et al., 
2015) or hypertension (Erikson et al., 1997; Whelton et al., 2002; Mohr et al., 2014). 
Although the effect of exercise training has been studied in persons with metabolic 
abnormalities, these studies are often confounded by weight loss, as it is well known that 
weight reduction is associated with an improved metabolic profile (Lang et al., 2011., Mason 
et al., 2011; Fisher et al., 2012; Prior et al., 2014; Beavers et al., 2014). Therefore, the effect 
of exercise training in persons with metabolic abnormalities in the absence of weight loss is 
not clear. In this section I will highlight some studies showing whether exercise can 
ameliorate the characteristic metabolic abnormalities in metabolic syndrome with or without 
weight change.  
Exercise is one lifestyle intervention that may attenuate the different risk factors constituting 
the metabolic syndrome. The effect of exercise on the risk factors of metabolic syndrome will 
be discussed in relation to a change in body weight. One of those risk factors is insulin 
resistance. Firstly, aerobic exercise enhances insulin sensitivity independent of changes in 
body weight or body composition (Larsen et al., 2014). Secondly, improvement in insulin 
sensitivity is accompanied by an improvement in mitochondrial function in diabetics (Meex et 
al., 2010). Thirdly, high intensity exercise has been shown to improve insulin–stimulated 
glucose disposal in obese subjects without decreasing body weight (Coker et al., 2006), 
whereas medium intensity exercise does not (Coker et al., 2006). However, exercise 
accompanied with weight reduction results in a down-regulation of myostatin mRNA and 
improves insulin sensitivity in obese older individuals (Ryan et al., 2013). Conversely, 
Trachta et al (2014) reported no change in insulin levels and blood pressure following 
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aerobic exercise despite decreased body weight. Furthermore, exercise did not improve the 
insulin resistance in individuals with metabolic syndrome without loss of body weight (Stuart 
et al., 2013). Although there is evidence that exercise improves insulin sensitivity, there is 
clearly controversy on this matter. What is the evidence that exercise mitigates 
hyperglycaemia? 
Evidence from clinical trials showed an improvement in hyperglycaemia with aerobic 
exercise. In this regard, aerobic exercise with concomitant weight loss in diabetics and 
prediabetics improved impaired glucose tolerance (Vancea et al., 2009; Malin et al., 2012; 
Solomon et al., 2013). This improvement is mediated through the enhancement of insulin 
sensitivity (Malin et al., 2013). Although some studies showed no improvement in glycated 
haemoglobin (HbA1c) following aerobic exercise (Vancea et al., 2009; McNeilly et al., 2012, 
Tunar 2012), other clinical trials showed that aerobic exercise can improve HbA1c (Sung et 
al., 2012; O'Neil et al., 2012; del Pozo-Cruz et al., 2014). Despite the controversial results 
obtained with regard to glycated haemoglobin, exercise may be effective in reducing the 
fasting blood glucose (Arciero et al., 1999; Vancea et al., 2009; Malin et al., 2013). 
Therefore, there is still a debate regarding the impact of exercise on glucose metabolism. 
Moreover, the effect of exercise on other metabolic disturbances, such as dyslipidaemia and 
obesity, need to be discussed further. 
Although the effect of exercise on glucose metabolism is controversial, the effects of 
exercise on other metabolic syndrome characteristics, specifically obesity and dyslipidaemia, 
have also been investigated. There is a large amount of evidence provided by previous 
studies regarding the effect of aerobic exercise on dyslipidemic individuals. A summary of 
the studies on the effect of aerobic exercise on metabolic and cardiovascular diseases risk 
markers in humans is provided in Table 2.3. In this table, aerobic exercise was the only 
lifestyle intervention method introduced. In addition, whether exercise in dyslipidemic 
participants resulted in weight loss or not and whether the weight loss was associated with 
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Table 2.3: Effect of exercise on cardio-metabolic parameters in individuals with dyslipidaemia  
Article 
Starting 
BMI/B.Wt 
Number of 
participants 
Intensity Duration 
Blood 
pressure 
Glucose Insulin 
Body 
weight 
Blood lipid 
Ficker et al., 
2010 
27±5 
40 Moderate 4 months 
## ## ## -- ↓ LDL ↑HDL –TG 
Camhi et al., 
2010 
25±2 
328 60-80% max HR 1 year 
-- -- -- -- -- 
Sixt et al., 2010 90-98 kg 23 80% of max HR 6 months ## ↓ ## -- ↓TC↓LDL 
Watkins et al. 
2003 
>25 
53 70-80% max HR 3 months 
-- -- ↓ -- -- 
Green et al., 
2003 
26.8-28.8 
75 70-85% max HR 8 weeks 
-- -- ↓ -- -- 
Lewis et al., 1999 29 9 65% max HR 4 weeks ## ## ## -- --- 
Watt et al., 1976 179-183Ib 60 Low intensity 12 weeks ## ## ## -- -- 
Coghill et al., 
2008 
28 
67 Moderate 12 weeks 
↓SBP -- -- ↓ ↓TG↓LDL↑ HDL 
Yoshida et al., 
2010 
24.6 
25 Moderate 16 weeks 
≠≠ ≠≠ ≠≠ ↓ ↓TC↓LDL 
Yoo et al., 2003 26 54 Aquatic 12 weeks -- -- ≠≠ ↓ ↓TG↑ HDL 
Roussel et al., 
2009 
29-35 
153 60 % max HR 12 months 
↓ ≠≠ ≠≠ ↓ ↓TG↓TC↓LDL↑ 
HDL  
Drevenhorn et 
al., 2007 
28-30 
177 
Intermediate to 
high 
15 months 
↓SBP ≠≠ ≠≠ ↓ ↓TG 
Slentz et al., 
2005 
29.6 
225 
Vigorous/ 
moderate 
8 months 
≠≠ ≠≠ ≠≠ ↓ ↓ LDL 
Stewart et al., 
2005 
29.4 
104 60-90% max HR 6 months 
↓ -- -- ↓ ↓TC↓LDL↓TG↑ 
HDL 
Kraus et al., 2002 29.3 111 High /moderate 6-8 months ≠≠ ≠≠  ↓ ↓LDL↓TG↑ HDL 
Couillard et al., 
2001 
24-28 
200 55-75% vo2 max 20 weeks 
≠≠ ≠≠ ↓ ↓ ↓TG↑ HDL 
            (↑) increased, (↓) decrease, (--) No change, (≠≠) not measured, (SBP) systolic blood pressure  
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changes in cardiovascular or metabolic risk factors, was highlighted. Some studies showed 
an improvement in TChol levels as well as LDL, TG and HDL levels following a period of 
aerobic exercise and significant loss of body weight (Kraus et al., 2002; Stewart et al., 2005; 
Drevenhorn et al., 2007; Roussel et al., 2009; Yoshida et al., 2010). In a few other studies, 
there was an improvement in dyslipidaemia following exercise despite an unchanged body 
weight (Ficker et al., 2010; Sixt et al., 2010). Yet, in some other studies, there was no 
improvement of dyslipidaemia and no loss of body weight following aerobic exercise (Watt et 
al., 1976; Lewis et al., 1999; Watkins et al., 2003; Green et al., 2003; Camhi et al., 2010). In 
particular, the duration and intensity of the exercise was the same in two studies (Rousell et 
al., 2009; and Camhi et al., 2010). However, there was no change observed in blood lipid 
and body weight in Camhi study whereas both lipid concentrations and body weight were 
improved in Rousell study. The observed difference may be attributed to the fact that the 
population in Camhi study was selected as metabolic syndrome while the Rousell study 
population were dyslipidemic individuals. The presence of metabolic syndrome 
characteristics could delay/prevent the improvement of blood lipids. 
It is evident from these studies that the simultaneous effect of exercise and weight loss on 
dyslipidaemia was beneficial. This can be reflected positively in patients with metabolic 
syndrome in that a decrease in body weight accompanied by improved dyslipidaemia will 
reduce the cardiovascular risk factors in the metabolic syndrome figure. The reviewed 
studies showed that exercise intensity was inversely proportional to the impact on blood lipid 
and body weight (Stewart et al., 2005; Slentz et al., 2005; Drevenhorn et al., 2007). In the 
aforementioned studies the number of participants was clearly larger with committed weight 
reduction. Furthermore, from the studies in table 2.3, we can summarize that a greater loss 
of body weight is seen in individuals with a higher starting body mass index. Importantly, 
these studies present with a number of limitations such as the short duration of some studies 
that did not give enough time for exercise to induce significant changes. Also, not all the 
studies measured all the risk factors of metabolic syndrome and this may restrict a 
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comprehensive comparison with the measured parameters in the current study. Moreover, 
when interpreting these studies, one must take into consideration the differences between 
the studies with regards to in the intensity and duration of the exercise interventions. Thus, 
we can extract from Table 2.3 that once exercise ameliorates obesity it will improve the 
accompanied dyslipidaemia. On the other hand, exercise was less effective in the 
improvement of dyslipidaemia without decreased body weight.  
The acute effect of exercise following consumption of a specific meal and postprandial 
hyperlipidemia was widely investigated. Postprandial hypelipidemia is attenuated following 
high intensity exercise (Ferreira et al., 2011; Gabriel et al., 2012). It is preferable to 
investigate exercise and postprandial hyperlipidemia in humans rather than intervention with 
a diet known to be harmful, which cannot be followed for a long time because of ethical 
considerations. To my knowledge there have not been many exercise studies with a western 
diet over a long period of time. Therefore, animal models have been developed for longer 
interventions in order to investigate the effect of diet and exercise on the metabolic status of 
rats and the results are subsequently translated for human benefit. In this regard the extent 
of aerobic exercise on metabolic abnormalities induced by a western diet studied in animal 
model of the HFHS diet is shown in Table 2.4. In these studies, the effect of a HFHS diet 
without exercise was compared to the effect of exercise in conjunction with a HFHS diet. The 
HFHS diet in this table composed of a sucrose or a sucrose and starch from the rat’s chow. 
A HFHS diet without exercise induced obesity (Grimditch et al., 1988; Gauthier et al., 2006; 
Paulino et al., 2010; Ennequin et al., 2015), high blood glucose level (De Moraes et al., 
2008; La Favor et al., 2013), blood TG level (De Moraes et al., 2008; Gerbaix et al., 2013) 
and insulin resistance (Grimditch et al., 1988; De Moraes et al., 2008). The addition of 
aerobic exercise (running on a treadmill or running wheels) to the HFHS diet prevented most 
of these changes, including the elevated TG level (De Moraes et al., 2008; Gerbaix et al., 
2013), increased blood glucose (Grimditch et al., 1988; Fisher-Wellman et al., 2013) and 
insulin  
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Table 2.4 Effect of high fat-high sucrose diet and exercise in rats 
Article Strain Age Diet Duration Effect of diet Effect of exercise 
Grimditch et al., 
1988 
Male 
Sprague-
Dawley  
10 
weeks 
40 % fat 39 % 
sucrose, 21 % protein 
10 weeks 
↑ body weight glucose 
intolerance Insulin 
resistance 
↓ body weight Prevent 
glucose intolerance Prevent 
insulin resistance 
Gauthier et al., 
2003 
Female 
Sprague-
Dawley  
6 
weeks 
42 % fat, 36 % 
sucrose, 22 % protein 
8 weeks 
↑ body weight  ↑hepatic 
lipid 
↓body weight ↓hepatic lipid 
De Moraes et 
al., 2008 
Male 
Wistar 
10 
weeks 
26 % fat, 56 % 
sucrose, 18 % protein 
12 weeks 
↑ triglycerides↑glucose 
↑insulin impaired (V.R) 
↓ triglycerides No effect on 
glucose↓ insulin ↓body weight 
improves (V.R) 
Paulino et al., 
2010 
Male 
Wistar 
4 
weeks 
54% starch,20% fat, 
20% protein, 30% 
sucrose solution 
Diet for 25 weeks 
Exercise for 10 
weeks 
↑ body weight,  LV 
systolic dysfunction, No 
effect on BP 
↓ body weight Prevent ↓ LV 
fractional shortening, No 
effect on BP 
La Favor et al., 
2013 
Male 
Sprague-
Dawley  
5 
weeks 
34% sucrose, 6% 
starch, 23% fat, 
17.3% protein. 
12 weeks 
↑ body weight ↑ glucose 
– insulin oxidative stress-
impaired (V.R) 
↓body weight, ↓total 
cholesterol ↓oxidative stress-
improve (V.R) 
Fisher-Wellman 
et al., 2013 
Male 
Sprague-
Dawley  
5 
weeks 
14.8% protein, 44.6% 
fat, 34 % sucrose, 
6.2% starch 
12 weeks 
↑ fat mass ↑fasting blood 
glucose – insulin 
Oxidative stress 
Prevent ↑ fat mass, Prevent ↑ 
blood glucose, Improve 
oxidative stress 
Gerbaix et al., 
2013 
Male 
Wistar 
11 
months 
24.4 % fat, 22.2 % 
sucrose, 22.2% starch 
20.4% protein 
8 weeks exercise4 
months diet 
Obesity, ↑triglycerides  
↓leptin ↓adiponectin 
↓body weight, ↓ triglycerides 
↓ leptin ↓adiponectin  ↑NEFA 
Ennequin et al., 
2015 
Male 
Wistar 
 7 
months 
24.4 % fat, 22.2 % 
sucrose, 22.2% 
starch, 20.4% protein 
16 weeks + 8 
weeks 
↑ body weight, did not 
alter signalling pathway 
of neuregulin 1-no effect 
on glucose and insulin 
↓body weight, improve 
signalling pathway of 
neuregulin 1-no effect on 
glucose and insulin 
 (↑) increased, (↓) decrease, (--) No change, (≠≠) not measured, ↑NEFA (non-esterified fatty acid), a (artery), LV left ventricular
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resistance (Grimditch et al., 1988; De Moraes et al., 2008). Importantly however, the 
exercise intervention in a majority of these studies modified the metabolic status and obesity. 
Hence this concurrent change does not allow the assessment of the impact of exercise 
alone, independent of a change in body weight. 
To conclude, both human and animal evidence provided by the literature argued that 
exercise can ameliorate metabolic disturbances. Although exercise may improve some 
metabolic changes, there is still debate about whether exercise can do so without a loss of 
body weight, in particular, if exercise can ameliorate dyslipidaemia without a loss of body 
weight. Therefore, it is very important to elucidate the potential role of exercise in improving 
dyslipidaemia in animals that does not exhibit weight loss.  
 
2.5 Effect of exercise on cardiovascular parameters 
Although it is well known that exercise has a beneficial effect on cardiovascular disease risk 
factors (Williams et al., 2013; Mohr et al., 2014; Rodrigues., 2014) in persons with 
established metabolic syndrome risk factors, it is not clear whether exercise alone can 
prevent the progression to cardiovascular diseases, independent of intervention with a 
healthy diet (Steven et al., 2002; Christou et al., 2005; Millen et al., 2014). 
Nevertheless physical activity is widely recommended as an important lifestyle change that 
may help in the prevention of hypertension (Diaz et al., 2013; Huang et al., 2013; Brown et 
al., 2013). As hypertension is strongly associated with cardiovascular diseases risk, early 
intervention, either at the general population level or by targeting high risk populations such 
as overweight, physically inactive persons or those with a family history of hypertension, 
could lower the incidence of hypertension and its subsequent adverse effects (Erikson et al., 
1997; Whelton et al., 2002; Golbid et al., 2012; Mohr et al., 2014). In this regard, several 
mechanisms have been suggested for blood pressure reduction as a result of exercise 
training including, changes in blood vessel function and structure, modulation of the renin-
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angiotensin system and decreased sympathetic nervous system stimulation (Golbid et al., 
2012). On the other hand, aerobic exercise interventions have shown controversial results in 
hypertensive individuals with other metabolic syndrome risk factors. While some studies 
showed no improvement in the blood pressure of hypertensives with metabolic syndrome 
characteristics (Arsenault et al., 2009; Lima et al., 2012), others showed a decrease in blood 
pressure. However those studies that have shown an improvement in blood pressure after 
an exercise intervention reported an accompanied weight reduction (Malin et al., 2012; Choo 
et al., 2014). What is the evidence that exercise, independent of weight loss, can improve 
cardiovascular risk in people who already have dyslipidaemia? A summary of the most 
pertinent studies assessing the effect of aerobic exercise on cardiovascular disease risk 
factors in dyslipidemic individuals with other cardio-metabolic risk factors is provided in Table 
2.3. Four studies reported that aerobic exercise in dyslipidemic individuals resulted in 
improved blood pressure in conjunction with weight loss (Stewart et al., 2005; Drevenhorn et 
al., 2007; Coghill et al., 2008; Roussel et al., 2009). However, it is not known whether it is 
the exercise per se or the combination of exercise and weight loss that resulted in the 
improved blood pressure. Moreover, there was no change in blood pressure in those 
dyslipidemic individuals after the aerobic exercise intervention without a change in body 
weight (Watkins et al., 2003; Green et al., 2003; Camhi et al., 2010). Yoo et al (2003) 
showed no change in blood pressure despite the decreased body weight. Furthermore, what 
is the evidence that exercise can improve other cardiovascular risk markers in individuals 
with dyslipidaemia?   
In this regard Table 2.3 shows several studies with improved blood pressure in conjunction 
with the improvement of dyslipidaemia (Stewart et al., 2005; Drevenhorn et al., 2007; Coghill 
et al., 2008; Roussel et al., 2009; ). The simultaneous improvement of dyslipidaemia and 
blood pressure following exercise may emphasise the role of high blood lipids in the 
pathogenesis of blood pressure. Nevertheless, Yoo et al (2003) reported that blood pressure 
did not decrease despite the improved dyslipidaemia in another study. Additionally, in these 
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studies the improvement of dyslipidaemia and blood pressure was accompanied by weight 
loss. Hence, the effect of aerobic exercise on blood pressure was obviously in positive 
association with the change in body weight, where the decrease of body weight was 
accompanied by an improvement of blood pressure as well as dyslipidaemia. On the other 
hand, the effect of exercise on dyslipidaemia and blood pressure without loss of body weight 
is still not clear and needs to be investigated further. 
Further to cardiovascular disease risk factors, aerobic exercise is also reportedly effective in 
improving cardiac function in several diseases. Aerobic exercise in diabetic patients 
improves maximum oxygen consumption and insulin sensitivity (Schrauwen-Hinderling et al., 
2011). In heart failure patients, exercise leads to a simultaneous increase in left ventricular 
end diastolic volume (LVEDD) and arterial volume (Sahlén et al., 2011), and increases left 
ventricular filling pressure (Borlauget al., 2011) in patients with heart failure with a preserved 
ejection fraction. Furthermore, the effect of aerobic exercise has been investigated on 
several vasculatures as the renal and cerebral vasculatures (Murrel et al., 2013). Without 
loss in body weight, exercise has been shown to improve the endothelial function in pre-
hypertensive and hypertensive individuals (Kouamé et al., 1995; Beck et al., 2014). 
Furthermore, exercise improves cerebrovascular reactivity and decreases stroke risk and 
age related cerebral atrophy (Linkis et al., 1995; Murrel et al., 2013).  
Similarly, animal studies provide evidence regarding the effect of exercise on cardiovascular 
disease risk factors. Animal studies where an aerobic exercise intervention was 
implemented with a HFHS diet model, are summarized in Table 2.4. All of these studies 
were performed exclusively on rats. From the results, it is seen that in one study, despite the 
increased body weight, the blood pressure did not change with consumption of a HFHS diet 
and did not change with exercise, despite the loss of body weight (Paulino et al., 2010). 
Further to the cardiovascular disease risk factors, one study reported that the exercise 
intervention resulted in improved coronary artery endothelial function (La Favor et al., 2013) 
and two others reported a decrease in oxidative stress, a well-known contributing factor to 
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endothelial dysfunction (Fisher-Wellman et al., 2013; La Favor et al., 2013). Furthermore, 
Paulino et al (2010) studied the impact of exercise on the heart. They reported that exercise 
prevented the worsening of cardiac function in a long duration intervention with a HFHS diet 
(Paulino et al., 2010). Notably, these studies induced obesity with a HFHS diet in their 
animals and the exercise intervention decreased the body weight of these rats (Paulino et 
al., 2010; Fisher-Wellman et al., 2013; La Favor et al., 2013). Hence, the effect of exercise 
could be mediated through the weight reduction. Therefore, it is not clear whether the impact 
of exercise on the heart and vascular reactivity dysfunction induced by a HFHS diet is due to 
the loss of weight or due to the impact of the exercise itself. Therefore, it is essential to 
investigate the cardiovascular effect of exercise on animals that do not display weight loss to 
clarify the effect of exercise rather than the impact of weight loss. 
In summary, although exercise is a well-recognized, important lifestyle modification tool 
which is widely recommended in the management of cardiovascular risk factors, whether or 
not the effect of exercise is independent from the body characteristic, metabolic and 
cardiovascular parameters is still not clear. Therefore, further evaluation of the metabolic 
and cardiovascular role of exercise in non-obese animals without the confounding impact of 
weight loss needs to be investigated. In this regard a number of questions that arose from 
the above discussion will be addressed in the following chapters. Firstly, what is the impact 
of exercise on the metabolic status and blood pressure, particularly with regards to 
dyslipidaemia, in non-obese animals? Secondly, is the impact of exercise independent of 
weight change? Thirdly, does exercise ameliorate the other concomitant metabolic 
disturbances associated with dyslipidaemia in non-obese animals, particularly the lipid 
status? Additionally, what is the effect of a HFHS diet on the other metabolic parameters 
associated with dyslipidaemia, and what is the effect of a HFHS diet on these metabolic 
changes in the absence of an obesity. Finally what is the effect of a HFHS diet on the 
cardiovascular system without a change in body weight? 
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2.6 Aims and objectives 
The main aim of this study is to determine the impact of a westernized diet model 
intervention in inducing cardiovascular and metabolic changes and to investigate the effect 
of exercise on the cardiovascular and metabolic status in Sprague-Dawley (SD) rats. 
The objectives of this project are: 
 
1- To determine the effects of a short-term HFHS diet intervention in inducing the 
characteristics dyslipidaemia with or without the metabolic syndrome characteristics. 
2- To determine the effects of a short-term HFHS diet intervention on body weight, lipid 
profile, blood glucose, insulin concentration and glycated haemoglobin in 3-month-old 
SD rats. 
3- To determine the effects of a short-term HFHS diet intervention on blood pressure, heart 
functions and dimensions in 3-month-old SD rats. 
4- To determine the effect of exercise on metabolic and cardiovascular changes induced by 
a HFHS diet. 
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Chapter Three: Materials and 
Methods 
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3.1 Experimental groups and exercise protocol 
Rats were provided by the Central Animal Service (CAS) of The University of the 
Witwatersrand. The study protocol was approved by the animal ethics screening committee 
(AESC) of The University of the Witwatersrand (AESC number: 2013/51/04) and was 
conducted as shown in Figure 2.1. All rats were individually housed in rooms that were 
lighted between 07:00 and 19:00 with the room temperature between 23 and 26°C. Rats 
received the water and food ad libitum. Rats were weighed weekly using a digital scale 
(Snowrex Electronic Scale, Clover Scales, Johannesburg South Africa). 
 
The selection of rats was performed at the age of 4 weeks. The rats were housed in 
individual cages and had free access to a running wheel through an opening between the 
cage and the wheel. The running wheels were designed to allow rotation in only one 
direction to prevent unmeasured running. Cat Eye Micro Cyclocomputers (CC-6000, Cat 
Eye) were used for monitoring of distance (Kilometres) and duration of exercise (hours/day) 
(Woodiwiss et al., 2000). The rats were chosen over a 10-day period of voluntary training 
selection according to their performance and ability to run 2 or more kilometres per day 
(Woodiwiss et al., 2000). The “non-runners” were returned to stock. Of the 92 male Sprague-
Dawley (SD) rats, 48 “runners” SD male rats were selected. The rats continued to exercise 
until the age of 3 months for all groups. 
The diet and/or exercise intervention started at the age of 3 months and continued for a 
period of 9 weeks. The selected “runners” were randomly assigned into 4 groups. Rats in 2 
groups (group 2 and 4) continued to have free access to a running wheel and exercise 
whereas exercise was withheld in the other 2 groups (group1 and 3). Activities of rats from 
group 1 and 3 were not assessed but their activities cannot be referred as exercise. Groups 
2 and 4 were running 2.87 and 3.89 km/day, respectively (p=0.24). The rats in 2 groups 
(group 3 and 4) were fed a diet rich in fat and sucrose (high fat-high sucrose diet) whereas 
rats in the other 2 groups (group 1 and 2) continue to receive a standard rat diet. 
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Rats were assigned as follow: 
group1: Standard diet (ST) without exercise (n=12) 
group2: Standard diet (ST+E) with exercise (n=12) 
group3: High fat-high sucrose diet (HFHS) without exercise (n=12) 
group 4: High fat-high sucrose diet (HFHS+E) with exercise (n=12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Protocol with group assignation according to dietary/exercise intervention. ST, 
standard diet; HFHS, high fat-high sucrose diet; t, time; SD, Sprague-Dawley. 
 
 
1- Selection of “runners” at 4 weeks-old 
“Non-runners” return to 
stock 
2- Diet Intervention and/or exercise; t = 0 
Group 4 HFHS 
diet with exercise 
n=12 
Group 3 HFHS 
diet without 
n=12 
Group 2 ST diet 
with exercise 
n=12 
Group 1 ST diet 
without exercise 
n=12 
48 male SD rats 
“Runners” 
3 month-old on arrival 
 
3-Termination; t = 9 weeks 
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3.2 Diet compositions and preparation 
The standard animal chow diet (Epol, Centurion, South Africa) was composed of 2.78% fat, 
17.99% protein as well as 6.54% sugar and 28.76% starch. The HFHS diet consisted of 39% 
fat, 40% sucrose and 21% rat chow and starch (Barnard et al., 1998). The HFHS diet was 
composed of lecithinated fat powder (Berg+Schmidt, Hamburg, Germany), sugar (Selati, 
Malalane, South Africa) and the standard animal chow. Five percent water was added to the 
mentioned compositions. Rats ate new pellets every day; the pellets were prepared the day 
before and were allowed to dry and be hard enough for the animal to eat. Throughout the 
time of the dietary intervention, the daily amount of food consumed by each animal was 
determined on a daily basis using a digital scale. The daily food intake was calculated by 
subtracting the lifted amount of food of everyday from the total amount of the given food that 
day. 
 
3.3 Measurements and procedures 
 
3.3.1 Blood Pressure (BP) Measurement 
Blood pressure (BP) was measured at mid-day using a tail-cuff technique which employs 
Volume Pressure Recording (VPR) technology (CODA, Kent Scientific, Torrington USA) 
(Feng et al., 2009) every 3 weeks (Figure 2.2). The VPR sensor utilizes a specially designed 
differential pressure transducer to non-invasively measure the blood volume in the tail. In a 
warm and calm room, conscious rats were placed in restrainers and rat tails were placed on 
a heating platform. Two cuffs were positioned on the tail. An occlusion cuff was positioned in 
the middle of the tail and a VPR-cuff was positioned near the base of the tail. Both cuffs 
were connected to the CODA system. Rats were habituated before the first measurement for 
three consecutive days, in order to enable them to adapt to the procedure. Measurements 
were taken at midday to avoid diurnal variation. BP determined by the mean of 10 readings. 
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3.3.2 Blood measurements 
3.3.2.1 Fasting blood glucose and triglycerides (TG):  
The rats were fasted for 12 hours (overnight) before blood glucose and triglycerides 
measurements were determined. Measurements were done before starting the dietary 
intervention and then at the 3rd, 5th and 7th week and at termination (Figure 2.2).  A passively 
fallen drop of blood (approximately 20μl) was obtained by a pin prick (using 25 gauge 
needle) into the tail vain (Parasuraman et al., 2010) and a glucometer (Ascensia Elite, Bayer 
USA) was used to assess fasting blood glucose by using a reagent strip. Another drop of 
blood was obtained by a pinprick into the tail vain to assess the fasting TG using a TG meter 
(Accutrend Triglycerides, Roche diagnostics, Germany). The glucometer and TG meter were 
calibrated by the code stripes with each new package of test strips. 
 
3.3.2.2 Lipid profile 
Blood was obtained at termination by cardiac puncture. 4 ml of whole blood was centrifuged 
and 2 ml of serum was collected and stored at -20 °C. High density lipoprotein (HDL), non-
fasting triglycerides (nfTG) and total cholesterol (TC) were measured by enzymatic 
colorimetric method (Cobas 6000, Roche diagnostic, Germany). 
 
3.3.2.3 Haemoglobin A1C  
Glycated haemoglobin (HbA1c) was assessed by radioimmunoassay RIA (ADIVA HbA1c, 
Siemens Germany) using 100-μl of whole blood (+EDTA) as described above in section 
3.3.2.2. 
 
3.3.2.4 Serum insulin 
Serum insulin was measured using a solid phase two-site enzyme immunoassay (DRG 
Ultra-Sensitive Rat Insulin ELISA, DRG USA) Using 25-μl of serum. The Ultrasensitive Rat 
Insulin ELISA is based on the direct sandwich technique in which two monoclonal antibodies 
are directed against separate antigenic determinants on the insulin molecule.  
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 Once a week for every animal: 
Body weight 
Running distance measurements 
 Once every three weeks: 
Blood pressure measurements 
 Blood sampling (measurement of 
Blood glucose and blood triglycerides); at 0, 3, 6, and 9 weeks 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
Figure 3.2 Measurements and procedures during the diet/exercise intervention and at 
termination. 
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intervention and terminal 
procedures 
3 month-old male ‘’runner’’ SD rats (n=48) 
Time=0 
Blood pressure measurement 
Blood sampling 
Time=9 weeks 
Non-invasive blood pressure 
measurements 
Echocardiography 
Blood and tissue collection 
Blood vessel reactivity 
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3.4 Echocardiography 
Echocardiography was obtained at termination (Figure 3.2) by an experienced member of 
the research team from the Cardiovascular Pathophysiology and Genomic Research Unit 
(CPGRU). Echocardiography is a non-invasive technique, conferring minimal or no pain or 
discomfort to the animals (Woodiwiss et al., 2001). Rats were anaesthetised 15 minutes 
before the procedure by intramuscular injections of ketamine (100mg.kg-1) and xylazine 
(5mg.kg-1). An ultrasonic probe was placed on the chest of the animal. Left ventricular 
function, intrinsic myocardial systolic function and left ventricular dimensions were 
determined in vivo using two-dimensional directed M-mode imaging. During three 
consecutive beats (to ensure that there is no variability in vagal autonomic activity and heart 
rate), the internal dimensions and wall thickness of the left ventricle were measured in 
systole and diastole. From these dimensions, left ventricular endocardial fractional 
shortening (FSend), midwall fractional shortening (FSmid) and relative wall thickness (RWT) 
were determined using the following calculation: 
FSend = (LVEDD-LVESD)/LVEDD x 100  
FSmid = [(LVEDD+LVED PWT) -(LV ESD+PWES)]/ (LV EDD +PWED) x 100  
RWT = PWED/ (LVEDD/2)  
Where PWED = left ventricular end diastolic posterior wall thickness, PWES = left ventricular 
end systolic posterior wall thickness, LVEDD = left ventricular end diastolic diameter and 
LVESD = left ventricular end systolic diameter (Anarmourlis et al., 2006; Norton et al., 2008). 
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Figure 3.3 Echocardiographic image of the left ventricle of a HFHS diet fed rat (M-mode). A, 
left ventricular end diastolic diameter (LVEDD); B, left ventricular end systolic diameter 
(LVESD); C, left ventricular end systolic posterior wall thickness (PWES); D, left ventricular 
end diastolic posterior wall thickness in systole (PWED). 
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3.5 Vascular reactivity 
After the echocardiography, the anaesthetised rats underwent a thoracotomy and the heart 
was removed from the thoracic cavity. Thoracic aorta, kidneys and mesentery were also 
removed and placed in a cold modified Krebs-Ringer bicarbonate (control) solution (g/l: 6.89 
NaCl, 0.35 KCl, 0.27 CaCl2, 0.14 MgSO4, 0.16 KH2PO4, 2.1 NaHCO3, and 1.99 glucose).  
The modified Krebs solution was used in previous studies in our laboratory to preserve the 
tissues in a physiological environment identical to the body environment and prepared daily 
by the same person. Arteries were then isolated. Rings of renal and mesenteric arteries (2 
mm long) were cleaned of fat and connective tissue and were suspended in a wire 
myograph (model 610M, Danish Myo Technology, Aahrus, Denmark). Arteries were 
mounted as a ring and threaded over two parallel stainless steel wires. The wires were 
secured to two supports or "jaws" with one support attached to a precision micrometer 
(allowing manual control of vessel circumference and stretch). The other support was 
attached to a force transducer for measurements of force/tension development. The 
preparation was kept in a heated chamber filed with an oxygenated physiological salt 
solution at 37°C. The baseline tension of mesenteric artery was 1.56±0.07 mN and of renal 
artery was 2.01±0.01 mN.  
Vasoactive drugs were added into the chamber and the concentration-response 
(contractions or relaxations) curves of the preparation for the different vasoactives drugs 
were determined under isometric conditions (Christon et al., 2005). The following 
vasoactives drugs were added into the reactivity chamber in an increasing concentration-
dependent manner. Contraction responses to Phenylephrine (Phe, 1 nM - 0.1mM) and 
Potassium chloride (KCl, 1 mM to 120mM) were recorded. Blood vessels were dilated with 
Acetylcholine (ACh, 0.1 nM–100 μM) and Sodium nitroprusside (SNP, 1nM-100μM) under 
phenylephrine-induced contraction (Phe concentration=0.3-1μM). ACh is an endothelium-
dependant vasodilator whereas SNP (1μM-100μM) causes an endothelium independent 
relaxation. 
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3.6 Organs Mass: 
Immediately after termination of the animals, right kidneys, liver, adipose tissue were 
removed and weighed. Measurements were done by using a digital scale. These organs 
were stored at -80 °C. The heart was removed and weighted, and then dissected. The free 
wall of the right ventricle was trimmed off the septum of the heart and weighed; 
subsequently, the left ventricle with the septum was then weighed.  
 
3.7 Tibial length: 
The Tibia was disarticulated from the femur then defleshed. The bone was dried (50 °C) for 
5 days in the lab oven (Salvis lab, Switzerland) then weighed. Tibial length was measured by 
using a pair of Vernier calipers (Hi-impact, Djuca, South Africa). Bone density then 
calculated by using the tibial length and weight. 
Bone density: tibial weight (mg)/ tibial length (mm).  
 
3.8 Histology and aortic morphometric study 
Thoracic aortic artery was fixed in 10% buffered formaldehyde solution then embedded in 
paraffin wax and sectioned. Cross-sections (5μm) were stained with haematoxylin and eosin 
(H&E) and stained with orcein (figure 2.4). The stained sections were viewed with the light 
microscope (Nikon Optiphot, JAPAN). Aortic wall thickness (AWT) was determined by mean 
of 3 measures of the thickness at 3 different angles, including 0, 90, and 180 °C. The 
commercial software AUTOCAD 2014 was used to measure the thickness.  
 
3.9 Measurement of liver lipid and glycogen 
3.9.1 Hepatic lipid content 
Hepatic lipid content was determined using the procedure by Bligh and Dyer (1959). Firstly 
the frozen liver samples were thawed, thereafter 5-6 grams of each liver sample were 
immersed in 150 ml of a chloroform: methanol solution (2:1 ratio) (MERCK chemicals, South 
Africa). The samples were then sealed with Accu-seal and incubated at 4 °C overnight. 
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Following the incubation period, the samples where then filtered through filter paper 
(Whatmann, No. 1 size 50mm, England) into a separating funnel. 30ml of 0.9% saline 
solution were then added and mixed fully. The solution was then incubated at 4 °C overnight 
in order to separate into two distinct layers. Following the overnight incubation, the bottom 
layer in the separating funnel containing chloroform was titrated into a round bottom flask 
(SCOTT DURAN, Germany). The lipids were then extracted by evaporating the solvent 
obtained at 37 °C using a rotor evaporator for approximately 30 minutes (Labocon (Pty) Ltd, 
Krugersdorp, Transvaal, South Africa). The residual oil obtained was then made up to 20ml 
by adding chloroform. The 20ml solution was then extracted from the round bottom flask 
using a pipette and stored in a vial. Small vials were then re-dried at 50 °C for 15 minutes. 
To determine the percentage of lipids in each liver sample an aliquot of 2 ml was extracted 
from the 20ml vial solution and placed in a dry- pre-weighed vial. The vial was then re-dried 
at 50 degrees Celsius using an oven (Salvis R, Oakton Instruments, and USA). The vial was 
then weighed on a digital lab scale and the mass of the lipid obtained was multiplied by a 
factor of 10, and recorded as a percentage of the original liver sample weight. 
 
3.9.2 Hepatic Glycogen Content 
Hepatic glycogen was determined using the process of indirect hydrolysis that was proposed 
by Passonneau and Lauderdale (1974). Firstly 0.1g of the liver sample was homogenized in 
1ml 0.03M hydrochloric acid using an ultra turrex homogenizer (Janke & Kunkel GmbH & Co 
IKA-Werk D7813, Staufen). 1 milliliter of 1M hydrochloric acid was then added in order to 
hydrolyse the liver glycogen. The test tubes were then sealed and placed in boiling water for 
2 hours. 1ml 1M sodium hydroxide was then added to each test tube in order to neutralize 
the acid before determining the glucose concentration. The glucose concentration was 
determined using a glucose-oxidase based reaction on the Accu-Check Active Glucose 
meter (Roche, Germany). Glycogen concentration was recorded as the glucose equivalents 
in the homogenate. 
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Figure 3.4 photomicrography of thoracic aortic wall section. (A) Aortic wall section stained 
with orcein stain. (B) Aortic wall section stained with H&E (Hematoxylin and eosin). 
 
A 
B 
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3.10 Data analysis 
 
Data is expressed as mean ± SD. Data analysis was performed using SAS software v. 9.3 
(SAS institute Inc, Carry, NC) and GraphPad Prism 5 software (Graph-pad Software Inc., 
San Diego, USA). The mixed model was used to analyse parameters measured each week 
namely blood pressure, fasting blood glucose, fasting blood triglycerides and body weight. A 
two way ANOVA followed by a Tukey-Kramer post hoc analysis was used to determine the 
difference between groups of the parameters measured at termination; namely non-fasting 
blood TG, HDL cholesterol, total cholesterol, insulin level, HbA1C, echocardiography, 
vascular reactivity, the heart weights, hearts function, heart dimensions, liver weights, 
hepatic glycogen contents, hepatic lipid contents, visceral adipose tissue weights, right 
kidney weights and thoracic aortic wall thickness. Median and range was reported for the 
non-normally distributed data. Differences were considered statistically significant at P ≤ 
0.05.  
The mixed model used for repeated measurements including blood glucose, blood 
triglycerides, blood pressures and body weight are: 
Yabcd=∑+E a + R b +TC+ Dd +∂ 
Yabcd =blood glucose at time T fasting blood glucose 
∑= mean for all observations 
Ea = effect of exercise on blood glucose (n=0, 2….9) 
Rb = fixed effect of each rat (n=1, 2…48) 
TC = fixed effect of time on blood glucose (n=1, 2….5) 
Dd = fixed effect of diet on blood glucose (n=0, 2….9) 
∂ = random error 
The model was the same for blood triglycerides, blood pressures and body weight. The 
factors used in the analysis were diet, exercise and diet-exercise. 
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Chapter Four: Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
52 
 
4.1 The effect of short term high fat-high sucrose diet and exercise on food intake, 
body weights, visceral adipose tissue weights, kidney weights and liver weights 
Figure 4.1 shows the effect of short term HFHS diet and exercise on weekly body weight in 
the different groups. Body weights of rats fed with standard diet increased throughout the 9 
weeks. Body weights of rats fed HFHS diet decreased in the first 2 weeks then increased 
until the end of the dietary intervention. Rats fed with HFHS diet were significantly lighter 
compared to the rats fed with standard diet by the end of first week (p<0.01) and continued 
to be lighter up to the ninth week (p<0.0001). Figure 4.2 shows the food intake of rats fed the 
HFHS diet or the standard diet with or without exercise. Food intake was significantly higher 
in rats fed the HFHS diet compared to the standard diet (p<0.0001). No differences in body 
weight and food intake were observed between the exercising and non-exercising groups (p 
=0.5517 and p=0.1806, respectively). 
Table 4.1 shows the effect of short term HFHS diet and exercise on weights of the liver, right 
kidney and visceral adipose tissue as well as tibiae lengths. Liver and right kidney weights of 
rats fed the HFHS diet were significantly lighter than those of rats fed the standard diet 
(p<0.0006 and p=0.0032, respectively). Liver, right kidney and visceral adipose tissue 
weights relative to body weight of rats fed the HFHS diet were similar to those of rats fed the 
standard diet (p=0.9798, p=0.8106 and p=0.3137, respectively). No difference was observed 
in liver and right kidney weights of rats that were exercising compared to those that were not 
exercising (p=0.9165 and p=.01944, respectively). Visceral adipose tissue weight in rats fed 
the HFHS were similar to those of rats fed the standard diet (p=0.3392). No difference was 
observed in visceral tissue weights of rats that were exercising compared to those that were 
not exercising (p=0.0553). Tibial lengths were similar in the 4 experimental groups 
(p=0.7381 for diet and p=0.9927 for exercise). 
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Figure 4.1: Effect of short term HFHS diet and exercise on body weights. Data are 
expressed as means ± SD. n=12 per group. ST, standard diet; ST+E, standard diet with 
exercise; HFHS, high fat high sucrose diet; HFHS+E, high fat high sucrose diet with 
exercise. * P < 0.05 for standard diet compared to high fat-high sucrose diet. 
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Figure 4.2: Effect of short term high fat-high sucrose and exercise on food intake. Data are 
expressed as means ± SD, n=12 per group. ST, standard diet; ST+E, standard diet with 
exercise; HFHS, high fat high sucrose; HFHS+E, high fat high sucrose with exercise. * P < 
0.05 for standard diet compared to high fat-high sucrose diet.  
 
 
 
 
 
 
 * 
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Table 4.1 Effects of dietary intervention and exercise on tibia lengths, liver weights, right     
kidney weights and visceral adipose tissue weights. 
 
Data are expressed as means ± SD, n=12 per group. TL, tibia length; LW, liver weight; 
RKW, right kidney weight; VATW, visceral adipose tissue weight; ST, standard diet; ST+E, 
standard diet with exercise; HFHS, high fat-high sucrose; HFHS+E, high fat-high sucrose 
with exercise. * P < 0.05 for standard diet compared to high fat-high sucrose diet. ns, non-
significant.          
    
    
  
     
 
   
 
  
ST 
 
ST+E 
 
HFHS 
 
HFHS+E 
Significance 
level 
 
TL (cm) 
 
4.50±0.18 
 
    
4.51±0.14 
 
 
   4.53±0.17 
 
                   
4.52±0.1
4 
  Diet   exercise 
     ns         ns 
 
LW (g) 
 
 
16.48±1.7
2 
 
16.03±1.3
5 
 
14.36±1.12* 
 
14.80±1.85* 
 
P<0.0006   ns 
 
RKW (g) 
 
1.70±0.18 
 
1.82±0.21 
 
  1.56±0.19* 
 
1.59±0.21* 
 
P=0.0032   ns 
 
VATW (g) 
 
6.43±1.10 
    
5.41±1.87 
        
   7.01±2.13 
    
   5.84±2.73 
 
      ns        ns      
 
LW/BWx100 (%) 
 
3.27±0.28 
 
3.16±0.27 
 
  3.21±0.28 
   
   3.23+0.40 
 
      ns        ns     
 
 RKW/BWx100 (%) 
 
 
 
0.34±0.11 
 
0.35±0.11 
 
   0.34±0.11 
     
   0.35±0.05 
 
      ns        ns 
         
 
 VATW/BWx100 
(%) 
  
 
1.26±0.21 
 
 
1.06±0.36 
 
  1.56±0.43 
     
   1.26±0.56 
 
ns        ns     
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4.2 The effect of short-term high fat–high sucrose diet and exercise on cardiovascular 
parameters 
4.2.1The effect of high fat–high sucrose diet and exercise on heart weights, 
dimensions and function as well as aortic wall thickness 
Table 4.2 shows the effect of short term HFHS and exercise on heart weight (HW), right and 
left ventricular weights (RVW and LVW, respectively) and thoracic aortic wall thickness 
(AWT). At 9 weeks, HW, RVW, LVW and thoracic aortic wall thickness in rats fed with HFHS 
diet were similar to those of rats fed the standard diet (P=0.2727, p=0.6625, p=0.6086 and 
p=0.7898, respectively). HW, LVW and thoracic aorta wall thickness of rats that were 
exercising were similar to those rats that were not exercising, despite the dietary intervention 
(p=0.1520 p=0.5906 and p=0.3794 respectively). RVW of rats that underwent exercise were 
heavier compared to those that did not perform exercise (p=0.0462).  
Table 4.3 shows the effect of short term HFHS and exercise on the left ventricular end 
diastolic (LVEDD) and end systolic diameters (LVESD), posterior wall thickness in diastole 
(PWED) and systole (PWES) and relative wall thickness (RWT). No differences were 
observed in LVEDD, LVESD, PWED, PWES and RWT of rats fed with HFHS diet compared 
to those of rats fed with standard diet (p=0.4046, p=0.4824, p=0.8115, p=0.7171 and 
p=0.6316, respectively) or in rats that underwent exercise compared to those rats that did 
not exercise (p=0.7318, p=0.6167, p=0.1742, p=4529, and p=0.3404respectively). 
Table 4.3 shows the effect of short term HFHS and exercise on the left ventricular systolic 
chamber function as indexed by endocardial fractional shortening (FSend) and intrinsic 
myocardial systolic function as indexed by intrinsic midwall fractional shortening (FSmid). 
FSend and FSmid were similar in the 4 experimental groups (p=0.7051 and 0.4224, 
respectively, for diet and p=0.4776 and p=0.3906, respectively, for exercise).  
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TABLE 4.2 Effects of the dietary intervention and exercise on heart weights, left ventricular 
weights and right ventricular weights. 
 
Data are expressed as means ± SD, n=12 per group. HW, heart weight; RVW, right 
ventricular weight; LVW, left ventricular weight; AWT, aortic wall thickness; ST, standard 
diet; ST+E, standard diet with exercise; HFHS, high fat-high sucrose diet; HFHS+E, high fat-
high sucrose diet with exercise. * P < 0.05 groups with exercise compared to groups without 
exercise. ns, non-significant. 
 
 
  
         ST 
 
 ST+E 
 
  HFHS 
 
HFHS+E 
Significance 
level 
 
HW (g) 
 
 
   1.21± 
0.12 
 
 1.16±0.12 
 
 1.18±0.10 
 
      1.22±0.11 
   Diet  exercise 
   ns         ns 
 
RVW (g) 
 
 
  0.25±0.03 
 
0.29±0.04* 
       
0.27±0.05 
  
      0.28±0.05* 
 
   ns   p=0.0462  
 
LVW(g) 
 
 
     
   0.96±0.12 
   
 0.97±0.10 
  
 0.90±0.11 
    
       0.94±0.11 
 
    ns      ns 
 
HW/BWx100 
 
     
0.24±0.01 
   
 0.25±0.02 
   
 0.26±0.02 
   
       0.27±0.03 
 
    ns      ns      
 
RVW/BWx100 
 
    
    0.05±.01 
   
 0.06±0.01 
   
 0.06±0.01 
    
       0.06±0.01 
 
    ns      ns     
 
LVW/BWx100 
 
     
 0.19±0.01   
   
 0.19±0.02 
  
   0.20±.03 
    
       0.20±0.02 
 
    ns      ns 
         
 
AWT (µm) 
 
 
  195±0.15 
 
       
 132±0.09 
   
     
  173±0.13    
 
      150±0.09 
 
ns      ns     
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Table 4.3 Effect of short term high fat-high sucrose diet and exercise on left ventricular 
dimensions and functions as assessed in vivo 
 
Data are expressed as means ± SD, n=12 per group.LV, left ventricle; EDD end diastolic 
diameter; ESD, end systolic diameter; PWED, posterior wall thickness at end diastole; 
PWES, posterior wall thickness at end systole; FSend, endocardial fractional shortening; 
FSmid, midwall fractional shortening; RWT, relative wall thickness; ST, standard diet; ST+E, 
standard diet with exercise; HFHS, high fat-high sucrose diet; HFHS+E, high fat-high 
sucrose diet with exercise. ns, non-significant. 
 
  
ST 
 
ST+E 
 
HFHS 
 
HFHS+E 
Significance 
level 
 
  LVEDD (mm) 
 
 
 6.78±0.66 
       
   6.83±0.48 
     
 6.76±0.26 
 
6.64±0.36 
   Diet  exercise 
    ns      ns 
 
  LVESD (mm) 
          
3.11±0.72 
       
   3.16±0.75 
         
 3.21±0.32 
 
2.95±0.35 
 
    ns       ns 
 
  PWED (mm) 
   
1.98±0.32 
 
 2.12±0.48 
         
1.98±0.20 
 
2.13±0.27 
 
    ns      ns 
 
  PWES (mm) 
     
 2.94±0.40 
 
  2.89±0.41 
 
   2.8±0.29 
 
2.94±0.39 
 
    ns      ns      
 
  FS end (%) 
   
54.18±6.6
3 
 
53.94±8.52 
  
52.57±6.3
5 
 
     55.72±4.09 
 
    ns      ns     
 
  FS mid (%) 
  
30.82±4.7
0 
   
32.21±6.85 
 
31.33±5.5
6 
 
     32.96±4.33 
 
    ns      ns 
         
 
  RWT (mm) 
   
0.59±0.12 
 
 
0.63±0.15 
    
0.59±0.07 
 
0.64±0.08 
 
ns      ns     
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4.2.2 The effects of short term high fat-high sucrose diet and exercise on blood 
pressure.  
Figure 3.3 shows the effect of short-term HFHS diet and exercise on systolic and diastolic 
blood pressure (SBP and DBP respectively). Figure 3.3 (A) and (B) show the SBP and DBP, 
respectively, in rats fed the HFHS and rats fed the standard diet at baseline (0), 3, 6 and 9 
weeks. SBP of rats fed the HFHS diet was significantly higher compared to that of rats fed 
the standard diet at the 6th (p< 0.05) and 9th week (p<0.05). There was a trend towards 
significance in the DBP of rats fed the HFHS diet compared to that of rats fed the standard 
diet (p=0.0573). 
No differences were observed in SBP or DBP between the exercising and non-exercising 
groups. (p=0.3954 and p=0.3954, respectively).   
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Figure 4.3 Effects of short term high fat-high sucrose diet and exercise on blood pressure. 
Panel A shows systolic blood pressure assessed in several points of time. Panel B shows 
diastolic blood pressure assessed in several points of time. Data expressed as means ± SD, 
n=12 per group. ST, standard diet; ST+E, standard diet with exercise; HFHS, high fat-high 
sucrose diet; HFHS+E, high fat-high sucrose diet with exercise. * P < 0.05 for the standard 
diet compared to high fat-high sucrose diet. 
 * 
 
 P=0.057 
     A  
     
     B  
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4.2.3The effects of short term high fat-high sucrose diet and exercise on vascular 
reactivity 
Table 4.4 and 4.5 show the effect of short-term HFHFS diet and exercise on vascular 
reactivity in renal and mesenteric artery rings. The results are expressed in Emax and EC50; 
Emax is the maximum contraction response and EC50 is the half maximum contraction 
response. No differences were observed in phenylephrine-induced contractions in 
mesenteric and renal arteries of rats fed the HFHS diet compared to those of rats fed the 
standard diet (p=0.0884 and p=0.9811 for Emax, respectively, and p=0.3728 and p=0.5232 
for EC50, respectively,). No differences were observed in KCl-induced contractions in 
mesenteric and renal arteries of rats fed the HFHS diet compared to those of rats fed the 
standard diet (p=0.5629 and p=0.1716 for Emax, respectively, and p=0.2222 and p=0.4591 
for EC50, respectively). Phenylephrine and KCl-induced contractions in rats that underwent 
exercise were similar to those in rats that did not exercising (p>0.05).  
Acetylcholine-induced relaxations in mesenteric and renal arteries of rats fed the HFHS were 
similar to those of rats fed the standard diet in (p=0.2246 and p=0.5589 for Emax, 
respectively, and p=0.4420 and p=0.6991 for EC50, respectively). Sodium nitroprusside-
induced relaxations in mesenteric and renal arteries of rats fed the HFHS were similar to 
those of rats fed the standard diet (p=0.4563 and p=0.4538 for Emax, respectively, and 
p=0.9679 and p=0.7289 for EC50, respectively). Acetylcholine and SNP-induced relaxations 
in rats that underwent exercise were similar to those in rats that did not exercise (p>0.05). 
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Table 4.4 Effect of short-term high fat-high sucrose diet and exercise on vascular reactivity 
in mesenteric artery 
 
Data expressed as means ± SD, n=12 per group.  Phe, Phenylephrine; KCl, Potassium 
chloride; A.Ch, Acetylcholine; SNP, Sodium nitroprusside; Emax, maximum contraction 
response, EC50; half maximum contraction; Emax for Phe and KCl expressed in mN; Emax 
for Ach and SNP expressed as % of Phe-induced contraction, EC50 expressed in  µmole 
(µm). ST, standard diet; ST+E, standard diet with exercise; HFHS, high fat-high sucrose diet; 
HFHS+E, high fat-high sucrose diet with exercise. ns, non-significant. 
 
 
 
 
 
                    
ST 
          
       ST 
 
       ST+E 
ST 
                 
HFHS 
  
            
S
T 
  
H
F
H
S 
 
H
F
H
S
+
E 
 
 
HFHS+E 
Significance 
level 
Phe 
Emax (mN) 
 
21.02±10.15 
 
16.75±7.4 
 
21.41±8.00 
 
25.40±5.91 
 Diet exercise 
  ns      ns 
EC50 (µm)    1.7±6.12 
 
1.03±7.1 
 
1.77±12.9 
 
 9.83±3.00 
 
  ns      ns 
KCL 
Emax (mN) 
 
 11.42±4.68 
 
7.85±3.09 
 
11.59±1.49 
 
12.14±3.91 
 
   ns     ns 
EC50 (µm)  0.06±0.03 
 
0.05±0.04 
 
0.03±0.02 
 
  0.05±0.03 
 
   ns     ns 
ACh 
Emax (%) 
 
 31.02±18.0 
 
 
16.2±26.08 
 
 
 17.7±21.57 
 
 
12.45±16.1 
 
 
   ns     ns 
EC50 ( µm) 9.36±12.89 
 
1.26±14.73 
 
3.06±12.81 
 
1.69±11.13 
 
   ns     ns 
SNP 
Emax (%)  
EC50 ( µm) 
 
17.79±12.47 
1.66±21.46 
 
 
 
28.51±30.24 
5.35±4.77 
 
 
13.68±8.72 
1.41±12.03 
 
 
23.96±13.6 
7.41±7.47 
 
   ns    ns  
   ns    ns 
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Table 4.5 Effect of short-term high fat-high sucrose diet and exercise on vascular reactivity 
in renal artery  
 
Data expressed as means ± SD, n=12 per group.  Phe, Phenylephrine; KCl, Potassium 
chloride; A.Ch, Acetylcholine; SNP, Sodium nitroprusside; Emax, maximum contraction 
response, EC50; half maximum contraction; Emax for Phe and KCl expressed in mN; Emax 
for Ach and SNP expressed as % of Phe-induced contraction, EC50 expressed in  µmole 
(µm). ST, standard diet; ST+E, standard diet with exercise; HFHS, high fat-high sucrose diet; 
HFHS+E, high fat-high sucrose diet with exercise. ns, non-significant. 
 
 
 
 
 
                    
ST 
          
       ST 
 
       ST+E 
ST 
 
HFHS 
  
            
S
T 
  
H
F
H
S 
 
H
F
H
S
+
E 
 
 
HFHS+E 
Significance 
level 
Phe 
Emax (mN) 
 
16.21±5.35 
 
17.28±5.98 
 
14.21±5.20 
 
19.20±4.28 
Diet exercise 
  ns    ns 
EC50 (µm)    5.42±3.81 
 
6.77±5.79 
 
9.83±8.55 
 
  4.92±3.15 
 
  ns    ns 
KCL 
Emax (mN) 
 
 9.88±6.76 
 
21.81±12.93 
 
7.88±4.92 
 
14.40±5.94 
 
  ns    ns 
EC50 (µm)  0.04±0.02 
 
0.11±0.08 
 
0.07±0.10 
 
  0.04±0.02 
 
  ns    ns 
ACh 
Emax (%) 
 
32.32±21.48 
 
 
19.62±11.68 
 
 
15.46±20.9 
 
 
28.98±21.01 
 
 
  ns    ns 
EC50 ( µm) 1.1±14.07 
 
6.17±6.36 
 
2.99±3.63 
 
1.08±24.21 
 
  ns    ns 
SNP 
Emax (%)  
EC50 ( µm) 
 
25.34±18.52 
2.76±5.85 
 
 
 
24.48±13.32 
4.59±5.52 
 
 
26.45±11.9 
1.96±4.95 
 
 
30.62±15.35 
2.29±5.43 
 
  ns    ns  
  ns    ns 
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4.3 The effect of high fat–high sucrose diet and exercise on metabolic parameters 
4.3.1 The effects of high fat–high sucrose diet and exercise on fasting blood glucose, 
Hemoglobin A1c and insulin level  
Figure 4.4 shows the effect of short term HFHS diet and exercise on fasting blood glucose 
level in rats fed the HFHS diet and rats fed the standard diet at baseline (0), 3, 5, 7 and 9 
weeks. Fasting blood glucose of rats fed the HFHS was similar to those of rats fed the 
standard diet (p=0.17). No difference was observed in fasting blood glucose of the rats that 
were exercising compared to those that were not exercising (p=0.84). Table 4.6 shows the 
effect of short term HFHS diet and exercise on hemoglobin A1C and insulin concentration in 
the different groups. No difference was observed in HbA1c concentration of rats fed the 
HFHS diet compared to those of rats fed the standard diet (p=0.61). No difference was 
observed in HbA1C of the rats that were exercising compared to those that were not 
exercising (p=0.20). Insulin level of rats fed the HFHS was similar to those of rats fed the 
standard diet (p=0.52) and also between the rats that were exercising compared to those 
that were not exercising (p=0.6).  
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Figure 4.4 Effects of short term high fat-high sucrose diet and exercise on fasting blood 
glucose. Data are expressed as means ± SD, n=12. ST, standard diet; ST+E, standard diet 
with exercise; HFHS, high fat high sucrose diet; HFHS+E, high fat high sucrose diet with 
exercise.  
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Table 4.6 Effects of short-term high fat-high sucrose diet and exercise on Hemoglobin A1c 
and insulin level. 
 
 
Data are expressed as means ± SD, n=12 per group. HbA1c, hemoglobin A1C; ST, standard 
diet; ST+E, standard diet with exercise; HFHS, high fat-high sucrose diet; HFHS+E, high fat- 
high sucrose diet with exercise. ns, non-significant. 
    
       ST        ST+E      HFHS       HFHS+E 
Significance               
level 
 
HbA1c (%) 
 
3.50±0.20 
 
 0.07% 
 
 0.07% 
 
 
   3.40±0.24 
 
3.50±0.39 
 
 
 
 
   3.39±0.22 
 
 
 
 
        ns 
 
Insulin (µg/l) 
 
0.044±0.00 
 
 0.044±0.00 
 
0.043±0.00 
 
0.044±0.00 
 
        ns 
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4.3.2 Effect of short term- high fat–high sucrose diet and exercise on fasting blood 
triglyceride and lipid profile  
Figure 4.5 shows the effect of short-term HFHS diet and exercise on fasting blood 
triglycerides at baseline (0), 3, 5, 7 and 9 weeks. Fasting triglycerides of rats fed the HFHS 
diet were significantly higher compared to those of rats fed the standard diet on the 3rd 
(p<0.001), 5th (p<0.001), 7th (p<0.001) and 9th week (p<0.01). No differences were observed 
in fasting blood triglycerides of the rats that were exercising compared to those that were not 
exercising (p=0.2131).  
Figure 4.6 shows the effect of short-term HFHS diet and exercise on the lipid profile in the 
different groups, including non-fasting blood triglycerides, TC and HDL cholesterol. Non-
fasting triglycerides and cholesterol of rats fed the HFHS diet were significantly higher 
compared to those of rats fed the standard diet (p<0.0001 and p=0.029, respectively). HDL 
cholesterol of rats fed the HFHS diet was significantly lower compared to those of rats fed 
the standard diet (p<0.0001). No differences were observed in non-fasting triglycerides, TC 
and HDL of the rats that were exercising compared to those that were not exercising 
(p=0.41, p=0.66 and p=0.22, respectively).   
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Figure 4.5 Effects of short term high fat-high sucrose diet and exercise on fasting blood 
triglycerides. Data are expressed as means ± SD, n=12 per group. ST,standard diet; ST+E, 
standard diet with exercise; HFHS,high fat-high sucrose diet; HFHS+E, high fat high sucrose 
diet with exercise. * P < 0.05 for standard diet compared to HFHS diet. 
 
 
 
 
 * 
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Figure 4.6 Effects of short term high fat-high sucrose diet and exercise on lipid profile. Data 
are expressed in means ±SD, n=12 per group. Panel A shows non-fasting blood triglycerides 
(nfBTG), panel B shows total blood cholesterol (TC) and panel C shows high density 
lipoprotien cholesterol (HDL). ST,standard diet; ST+E, standard diet with exercise; 
HFHS,high fat high sucrose diet; HFHS+E, high fat high sucrose diet with exercise. * P < 
0.05 standard diet compared to HFHS diet. 
 
A 
B 
 A 
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 * 
 * 
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4.3.3 Effect of short term- high fat–high sucrose diet and exercise on hepatic 
glycogen and lipid contents  
Table 4.7 shows the effect of short term HFHS and exercise on hepatic glycogen and 
hepatic lipid contents. Hepatic glycogen contents of rats fed the HFHS diet were significantly 
higher compared to those of rats fed the standard diet (p<0.02). Hepatic lipid contents of rats 
fed the HFHS were similar to those of rats fed with standard diet (p=0.73). No differences 
were observed in hepatic glycogen and lipid contents of the rats that were exercising 
compared to those that were not exercising (p=0.86, p=0.85, respectively).   
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Table 4.7 Effects of short-term high fat-high sucrose diet and exercise on Hepatic glycogen 
contents and Hepatic lipid contents. 
 
Data are expressed in means ±SD. Glycogen, hepatic glycogen contents (expressed as 
glucose equivalents (GE) in the liver homogenate); Lipid, hepatic lipid contents (expressed 
as percentage of the liver sample weight); ST, standard diet; ST+E, standard diet with 
exercise; HFHS, high fat high sucrose diet; HFHS+E, high fat high sucrose diet with 
exercise. * P < 0.05 standard diet compared to HFHS diet. ns, non-significant. 
 
 
 
 
 
 
 
 
     ST        ST+E     HFHS       HFHS+E 
Significance               
level 
 
Glycogen (GE) 
 
5.56±1.59 
 
 0.07% 
 
 0.07% 
 
 
   5.61±1.70 
 
6.65±1.40* 
 
 
 
 
   6.76±2.34* 
 
 
 
Diet     exercise 
P<0.02     ns     
 
Lipid (%) 
 
5.28±2.19 
 
   6.01±1.35 
 
6.12±2.54 
 
5.68±2.59 
 
  ns          ns 
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Table 4.8 Non-normally distributed data. 
 
TG, fasting triglycerides; Glycogen, hepatic glycogen; nfTG, non-fasting triglycerides; TCol, 
total cholesterol 
 
 
 
  
  ST 
 
ST+E 
 
HFHS 
 
HFHS+E 
Food intake (g/day) 
Median 
ra 
Range 
 
 
4.50±0.18 
 
    
4.51±0.14 
 
 
   4.53±0.17 
 
                   
4.52±0.14 
Range 56.17 
14.36±1.12* 
   29.11 
14.80±1.8
5* 
61.55 
16.48±1.72 
55.14 
16.03±1.35 
i    32.33  35.67 59.71 57.87 
TG (mmol/l) 
Median 
re 
 
  1.56±0.19* 
 
1.59±0.21
* 
 
1.70±0.18 
 
1.82±0.21 
Range 
H.glycogen 
me 
   2.58 
   7.01±2.13 
   1.63 
   
5.84±2.73 
 5.2 
6.43±1.10 
 5.40 
5.41±1.87 
edian 
Range 
in 
   1.54 
  3.21±0.28 
   1.50 
   
3.23+0.40 
 2.94 
3.27±0.28 
 2.31 
3.16±0.27 
Glycogen (GE) 
Median 
re 
 
   0.34±0.11 
     
   
0.35±0.05 
 
0.34±0.11 
 
0.35±0.11 
Range 
nfTG 
 
  4.6 
   
    3.9 
   
 4.6   5.9 
edian 
Range 
CH 
  5.2     5.2  6.3   6.6 
nfTG (mmol/l) 
 
    
Range   1.6       1  2.5   2.8 
Median   1.8      1.4  3.75   3.7 
TCol (mmol/l) 
 
    
Range   0.8      1.2 0.6   1.1 
Median   1.5       1.4 1.75   1.6 
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The discussion highlights the effects induced by feeding high fat-high sucrose (HFHS) diet 
for 9 consecutive weeks. The main finding of the current study is the development of 
dyslipidaemia and elevated systolic blood pressure accompanied by lower body weight gain 
in rats fed a HFHS diet for 9 weeks compared to the rats fed standard diet. Furthermore, the 
rats fed a HFHS diet also had a higher glycogen deposition in the liver. In addition this study 
showed that short-term exercise training for nine consecutive weeks did not attenuate the 
effects induced by the HFHS diet on blood lipids, systolic blood pressure as well as liver 
glycogen. 
 
5.1 The effect of a high fat–high sucrose diet on body weight and tibial length  
Studies have shown that a HFHS diet rat model has been used previously to model western 
diet-induced metabolic abnormalities such as obesity and metabolic syndrome (Barnard et 
al., 1998; Yamamoto et al., 2006; Bourgoin et al., 2008; Kong et al., 2011). Although a 
number of studies have reported an increase in body weight after a HFHS diet intervention 
(Barnard et al., 1998; Yamamoto et al., 2006; Bourgoin et al., 2008; Kong et al., 2011), not 
all studies that employed a HFHS diet observed a difference in the body weight gain of the 
rats (Arias et al., 2014, Pierine et al., 2014). In the current study, rats fed a HFHS diet 
weighed significantly less than the control groups. In agreement with our results, a previous 
study has reported that the rats that administered a HFHS diet for 12 weeks, weighed less 
than rats receiving a control diet (Hirotani et al., 2012). However, in this study, rats 
experienced liver disease. Furthermore, the results from Hirotani et al. (2012) should be 
interpreted carefully as the food intake of rats fed the HFHS diet was lower than the control 
group and hence the body weight gain of the rats was lower. Additionally, in the intervention 
group, lower blood glucose and triglycerides were justified by a decrease in body weight and 
abnormal lipid metabolism (Hirotani et al., 2012).  
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In the current study, the food intake of rats fed the HFHS diet was greater than that of rats 
fed the control diet. However, in the first two weeks of diet intervention, the body weights of 
rats fed HFHS diet were decreased. This could possibly be explained by that rats fed with 
the HFHS may have eaten less than they were supposed to eat in the first two weeks of the 
intervention as a result of introducing a new diet; hence rats fed the HFHS diet were lighter 
throughout the experiment. However, following the first 2 weeks, the growth rate was similar 
between the groups. Secondly, a habituation time which is suggested to adapt to a new diet 
(Ferraris et al., 1995; Levin et al., 2002) was not done in this study, but food intake may have 
corrected for the decreased body weight, where food intake in rats fed HFHS diet increased 
and was higher than the standard diet group. Thirdly, the HFHS diet was prepared in our 
laboratory and was mixed with water, in contrast to the standard diet which constituted of dry 
compositions only. This could have affected the percentage of vitamins and minerals in the 
diet, food efficiency and could have affected the caloric compositions of the diet. The 
essential vitamins and minerals were not added to the HFHS diet, which could lead to 
malnutrition of rats fed HFHS diet and subsequent lower body weight. Finally, the fat used in 
our diet was vegetarian fat, in contrast to the fat used in the other studies which was mainly 
lard (Yamamoto et al., 2002; Kong et al., 2011). It has been reported in previous studies that 
the diet which contains lard induces an increase of body weight more than other types of fats 
(Carmiel-Haggai et al., 2005; Buettner et al., 2006; Lionetti et al., 2014). All these reasons 
may explain the weight loss in the rats fed the HFHS diet during the first 2 weeks. 
Subsequent to the first two weeks, the food intake of rats fed the HFHS increased and the 
increase in body weight was similar between the experimental and control groups. However 
this increased food intake was not enough for rats fed the HFHS diet to catch up or exceed 
the weights of the control groups.  
Tibial length, another growth parameter, was not affected by consumption of the HFHS diet. 
This observation suggested that the growth of animals were similar between the 
experimental groups. We therefore cannot assume that malnutrition occured with the HFHS 
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diet. We can therefore conclude that, in our model and despite some experimental bias, the 
rats were not obese following consumption a HFHS diet for 9 weeks. In agreement with this 
conclusion, the visceral adipose tissue weights were not different between the experimental 
groups. 
 
5.2. The metabolic effects of a high fat–high sucrose diet  
5.2.1 Blood glucose, serum insulin, glycated haemoglobin and hepatic glycogen 
contents 
In the current study fasting blood glucose concentrations at termination were not different 
compared to the baseline readings in any of the groups. There are contradictory reports with 
regards to the effects of a HFHS diet on blood glucose with some studies reporting that such 
diets elevate blood glucose concentration (Barnard et al., 1998; Sugatani et al., 2006; Zhang 
et al. 2015) and others reporting no effect of HFHS diet on blood glucose concentration 
(Yamamoto et al., 2006; Chun et al., 2010; Stephenson et al., 2012). This discrepancy may 
be explained by the difference in the duration of the dietary intervention. Indeed, blood 
glucose concentration increases with the longer diet interventions (Barnard et al., 1998). In 
this study, the blood glucose concentrations did not change and this may be as a result of 
short duration of the intervention. A study by Sugatani and colleagues (2006) has shown an 
increase in blood glucose following short-term dietary intervention. However the percentage 
of carbohydrates in the former study was greater than in my study. The age of the animals at 
the beginning of the dietary intervention may possibly determine the incidence of increased 
blood glucose concentration. In the present study, the young age of the animals may allow 
them to handle the load of sucrose in the HFHS diet. In this study, glucose may have been 
transformed into lipids by de novo lipogenesis (Strable et al., 2010), thus blood glucose 
levels did not change.  
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In the current study, similar to glucose, no difference was observed in serum insulin 
concentration between the groups. Some studies observed similar results where no change 
was observed in serum insulin concentration (Sugatani et al., 2006; Yamamoto et al., 2006; 
Muraki et al., 2011; Cheng et al., 2014). Other studies reported contrasting results with an 
elevated insulin concentration following HFHS consumption (Barnard et al., 1998 and Zhang 
et al., 2015). This discrepancy may be explained in some case by a concurrent increase in 
blood glucose. Hyperglycaemia has been previously reported to compensate for the insulin 
resistance induced by a western diet (Commerford et al., 2001). Insulin is well known as the 
principle hormone responsible for glucose regulation in the blood. In the present study, the 
absence of change in insulin concentration may be explained in conjunction with an 
unchanged blood glucose concentration. As both blood glucose and serum insulin did not 
change with the 9 weeks consumption of HFHS diet, these findings suggest that these rats 
have no tendency to diabetes mellitus yet. 
Haemoglobin A1C (HbA1c) explains the glycosylation of haemoglobin and it reflects the 
status of blood glucose for at least 3 consecutive months. In the present study no difference 
was observed in HbA1c concentration between the groups. HbA1c concentration was in 
agreement with the unchanged blood glucose and insulin concentration. Hence, the absence 
of change in HbA1c could be explained by the absence of hyperglycaemia. Previous 
investigations observed similar results where no change was observed in HbA1c (Rosety-
Rodriguez et al., 2012; Cheng et al., 2014). Some studies found contrasting results with 
elevated HbA1c concentration when a HFHS diet was consumed (Medford et al., 2012). 
However in the former study the dietary intervention lasted 52 weeks which could explain the 
lack of change in the current study (Medford et al., 2012). Additionally in the present study, 
the absence of hyperglycaemia and HbA1c change may be explained by a low ambient 
temperature in the central animal unit. Rats fed HFHS diet may have used the glucose as an 
energy source for thermoregulation in order to maintain their body temperature (Balmagiva 
et al., 1983). 
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Finally, in the current study the rats fed the HFHS diet had an increased hepatic glycogen 
deposition. Liver is the main storage site for glucose in the form of glycogen. Previous 
studies have reported an increased glycogen deposition in the liver following consumption of 
a western diet (Mattar et al., 2010; Mousavi et al., 2012; Kjaergaard et al., 2014), whereas 
others found contrasting results without any change observed in hepatic glycogen deposition 
with HFHS diet consumption (, Commerford et al., 2001; Medford et al., 2012). A diet high in 
simple carbohydrates has been shown to promote glycogen deposition in the liver (Garrido 
et al., 1996; de Castro et al., 2013; Nasri et al., 2015; Maslak et al., 2015). In my study, 
because insulin concentration was within normal range, it is possible that glucose handling is 
normal and that glucose is either stored as glycogen in the liver or converted to fat to be 
stored instead of resulting in altered glucose metabolism and insulin resistance. 
 
5.2.2 Blood lipids  
High concentrations of triglycerides (TG), low density lipoprotein (LDL), total cholesterol 
(T,Chol) and low concentrations of HDL are considered markers of dyslipidaemia 
(Wietlisbach et al., 2013). In the current study high fasting and non-fasting TG, high TChol 
and a low HDL concentrations was observed following consumption of a HFHS diet 
compared to the standard diet group. It is well known that a diet high in fat induces elevation 
of blood lipids (Tzeng et al., 2012; Kumar et al., 2014; Zhukova et al., 2014), and therefore 
the high fat component in the present study may be responsible for the elevated blood lipids.  
Dyslipidaemia can be explained by the fact that the HFHS diet is composed of 39% fat. Fat 
content in the diet increases apolipoprotein concentration and subsequently increases the 
TG, LDL and TChol concentrations and lowers HDL concentration (Barnard et al., 1998). 
Furthermore, a high sugar load is well known to induce de novo lipogenesis (Strable et al., 
2010). Given the presence of an excessive amount of sugar that would metabolise into fat, 
this may be further increasing the blood lipids. On the other hand, glucose derived from 
metabolised carbohydrate either would be used for energy or directed to be stored in the 
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liver as glycogen (Foufelle et al., 2002; Ferrer et al., 2003). The large amount of glucose 
derived from HFHS diet exposes the liver to a large amount of glucose and would be stored 
it as glycogen (Bollen et al., 1998). Once the liver reaches the maximum storage capacity for 
glycogen the liver would use glucose for the de novo liponeogenesis and the formed lipids 
would be excreted as blood lipids (Foufelle et al., 2002). 
However, the visceral adipose tissue weights were not different between the experimental 
groups. It is well-known that lipids from the diet could be stored in the form of visceral 
adipose tissues. In our model, ingestion of high concentrations of fat and carbohydrate 
resulted in an elevated blood lipid concentration but no change in the storage of fat. 
Similarly to visceral adipose tissue, in the current study no change was observed in the 
hepatic lipid contents despite the elevated blood lipids concentration. This finding was in 
disagreement with findings from previous studies which reported an increased hepatic lipid 
contents (Sugatani et al., 2006; Muraki et al., 2011). This may be explained by the room 
temperature at the central animal unit which was less than the desired temperature for the 
rats (Maloney et al., 2014). Fat from the diet may have been used as an energy source to 
maintain normal body temperature (thermoregulation) of the rats (Balmagiva et al., 1983). 
Moreover my results could be explained by lack of obesity in the animals of the current 
study. In previous studies, obesity has been reported to induce an increase of lipid 
deposition in the liver (Uriarte et al., 2013; Kabel et al., 2014; Chu et al., 2015). Although 
liver weights of animals fed a HFHS diet were lower than the control group, the liver weights 
relative to body weights (normalized) showed no differences between the groups. These 
findings were similar to the findings from previous studies which found no difference in liver 
weights and liver weights relative to body weight following consumption of HFHS diet 
(Bourgoin et al., 2008 and Muraki et al., 2011, respectively). These observations (no change 
of the liver lipid contents and no change in liver weights) indicate that despite elevated blood 
lipids, the liver is well functioning. The aforementioned results suggest that the consumption 
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of a HFHS diet induces elevation of blood lipids without increased body weight and visceral 
adipose tissue and without affecting the liver function. 
 
5.3 The effect of a high fat–high sucrose diet on cardiovascular parameters 
5.3 .1 blood pressure 
In the current study the consumption of a HFHS diet for 9 weeks resulted in significant 
increase of systolic blood pressure (SBP) and there was a trend towards an increase in 
diastolic blood pressure (DBP) compared to the rats fed the control diet. Despite a lack of 
obesity, SBP still increased following the consumption of HFHS diet. In the present study, 
blood lipid concentration increased in conjunction with the raised SBP. The increased blood 
lipids could be responsible for the increased SBP as previous studies have associated the 
rise in blood pressure with dyslipidaemia (Barnard et al., 1998; Yamamoto et al. 2006; 
Bourgoin et al., 2008). An important factor that could be responsible for the raised SBP in 
these studies is the nature of the fat used, namely lard (saturated animal fat).  Saturated fat 
is well known to predispose rats to hypertension (Oliveira et al., 2013). The fat used in the 
current study was lecithinated fat (saturated vegetable fat). Lecithinated fat is composed of 
phosphatidyl choline, which is metabolised by the gastrointestinal tract into TMAO 
(Trimethylamine-N-oxide) (Mendelsohn et al., 2013). TMAO has been recently recognised to 
have adverse effects on the vasculature. In this regard TMAO has shown to induce 
atherosclerotic changes and increase oxidative stress, both which affects blood vessels 
remodeling and subsequently may predispose to an increased blood pressure (Mendelsohn 
et al., 2013). 
Inflammation is another suggested mechanism which has been linked to development of 
elevated blood pressure (Utimura et al., 2003; Gonçalves et al., 2004). In this regard 
Bourgoin et al (2013) linked the elevated blood pressure to the presence of endothelin-1 in 
the adipose tissue surrounding the blood vessel of animals consuming a HFHS diet. In the 
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current study, to determine the possible mechanism responsible for the raised blood 
pressure, the aortic wall thickness was measured as an indicator of vascular anatomical 
changes including atherosclerosis, increased wall to lumen ratio and microvascular 
rarefaction (Serné et al., 2007). Moreover, the reactivity of the medium-sized blood vessels 
was assessed to determine whether the increased blood pressure is associated with 
changes in vasodilation or vasoconstriction responses. No differences were observed in 
aortic wall thickness and vascular reactivity of the renal and mesenteric arteries between the 
rats fed a HFHS diet and rats fed the control diet. Hence the increased BP cannot be 
explained by changes in aortic wall thickness and vascular reactivity. Further investigations 
are therefore required to illuminate the mechanism responsible for the elevation in blood 
pressure.  
In order to determine the effect of raised blood pressure on the heart; heart weight as well as 
heart dimension and function were measured. Hypertension is one of the most common 
causes responsible for development of heart failure (Natsume et al., 1993; Carll et al., 2011). 
In the current study, although the animals fed the HFHS diet had dyslipidaemia and their 
blood pressure were elevated, no differences were observed between the groups with 
regards to heart weight, heart function or dimension. These findings suggest that the hearts 
of these animals have no tendency to hypertrophy or progress to heart failure. The absence 
of cardiac remodeling is most likely as a result of the short duration of raised blood pressure 
induced by the HFHS diet.  
 
5.4 Exercise effects on cardiovascular and metabolic parameters 
5.4.1 The effect of exercise on body weight of animals fed high fat–high sucrose diet  
Several studies have reported a decrease in body weight following exercise in animals 
consuming a HFHS diet (Paulino et al., 2010; La Favor et al., 2013; Ennequin et al., 2015). 
The present work shows that the exercise and sedentary groups had the same pattern of 
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change in body weight in both the control and HFHS dietary groups, suggesting that 
exercise for a short duration in dyslipidemic non-obese animals did not change the body 
weight of these animals. The discrepancy may be attributed to an increased body weight 
induced by the diet in the previous studies. Notably, some of the previous studies have 
induced obesity before starting the exercise intervention (Paulino et al., 2010; Gerbaix et al., 
2013; Ennequin et al., 2015) to ensure that those animals are obese.  In the current 
experiment, the HFHS diet did not induce obesity, despite the higher food intake in rats fed 
HFHS diet compared to rats fed ST diet. The higher food intake and lesser gain in body 
weight could be attributed to the initial weight loss and the water content of HFHS diet. 
Although the HFHS diet composed of a higher proportion of two macronutrients (fat and 
carbohydrates), it composed of a lower protein compared to the standard diet. The low 
protein content of the HFHS diet could affect the metabolism and caused a lower body 
weight as a result of protein energy malnutrition despite the higher food intake (de Melo 
Montenegro et al., 2012; Malta et al., 2014). Secondly a (slightly) shorter duration in my 
study compared to prior studies may have impacted the change in body weight. 
Furthermore, all selected rats have the ability to run voluntarily (runner). This particular 
feature may protect the rats from diet induced obesity (Ruegsegger et al., 2015). 
Furthermore, in the current study, no differences were observed in the visceral adipose 
tissue weights between the exercise and sedentary groups. Additionally, exercise did not 
change the food intake pattern for the exercise groups in comparison to the sedentary 
groups. These observations suggest that exercise did not modify the animals’ appetite as 
well as body weight regulation mechanism which subsequently did not change the body 
weight.  
Consumption of HFHS diet, obesity (Zernicke et al., 1995) and loss of body weight (Bodnar 
et al., 2012) are recognized factors that may predispose to negative impacts on bone 
characteristics. In the current study, exercise for 9 weeks did not change the bone length or 
bone mineral density in both dietary groups compared to the sedentary groups (data not 
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shown). This finding could be justified by the fact that the animals in the current study were 
not obese and also did not lose weight by exercise intervention. Data from these 
observations suggest that 9 weeks of exercise in non-obese animals did not change the 
growth pattern of the exercise groups. Human studies showed controversial results 
regarding the effect of exercise on body weight. Some studies found similar findings to our 
finding that exercise did not lower the body weight (Watt et al., 1976; Lewis et al., 1999; 
Green et al., 2003).  In these studies, the absence of loss in body weight could be attributed 
to the effect of exercise on the muscular compartment. Green et al (2003) recognised an 
increase of lean body mass (muscle mass) which indicated by decreased the percentage of 
body fat and no change in total body weight. In contrast, other human studies reported that 
exercise resulted in decreased body weight (Slentz et al., 2005; Drevenhorn et al., 2007; 
Roussel et al., 2009). The discrepancy in the resulted body weight could be attributed to the 
differences in the exercise protocol used in these studies with different intensity, duration 
and the concurrent diet consumed by the participants. Therefore, the effect of exercise in 
conjunction with HFHS diet needs further investigation.  
  
5.4.2 Exercise effect on blood glucose, serum insulin, glycated haemoglobin and 
hepatic glycogen contents 
Exercise is known to affect the control of blood glucose concentration. Exercise has been 
shown to ameliorate the raised blood glucose in animals fed HFHS diet (Fisher-Wellman et 
al., 2013), improved hyperinsulinemia (Grimditch et al.,1988) and to lower the high HbA1c 
concentrations in rats fed high fat diet (Heo et al., 2013). In the current study, fasting blood 
glucose, insulin and HbA1c concentrations were the same in both exercising groups and the 
sedentary groups, regardless of the diet consumed. Our findings are in agreement with 
those of previous studies showing that exercise did not change these parameters. Indeed, in 
animals fed HFHS diet, exercise did not change blood glucose (De Moraes et al., 2008) and 
insulin (La Favor et al., 2013) concentrations. However in these studies the blood glucose 
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(De Moraes et al., 2008) and insulin (La Favor et al., 2013) concentrations were increased 
with a HFHS diet. However, the length of the intervention was 10 weeks in Grimditch (1988) 
study and 12 weeks in both De Moraes (2008) and Fisher-wellman (2013). While the length 
of intervention in a study by Heo et al (2013) was 4 weeks. Nevertheless, we can assume 
that, similar to these studies, exercise did not drop blood glucose, insulin as well as HbA1c 
concentrations. Additionally, in my study the rats did not develop insulin resistance or 
increased blood glucose, hence with a normal glucose metabolism, exercise is unlikely to 
alter the metabolic pathways.  
In addition to the unchanged glucose, insulin and HbA1c exercise for 9 weeks in non-obese 
animals did not ameliorate the elevated liver glycogen content in the animal fed HFHS diet. 
Gluconeogenesis induced by exercise is known to utilize different substrates to synthetize 
the glucose including lipid, glycogen or lactate (Turcotte et al., 1990). In particular, the use of 
the dietary glucose as substrate for gluconeogenesis could be the cause of sparing the 
blood glucose and the subsequent prevented glycogenolysis of the elevated hepatic 
glycogen that induced by HFHS consumption. These observations suggest that exercise for 
9 weeks did not change the glucose metabolism of the non-obese animals and did not 
ameliorate the hepatic glycogen content. 
 
5.4.3 Exercise and blood lipids 
Previous animal studies have shown that exercise can ameliorate the raised blood lipids 
induced by HFHS diet consumption (De Moraes et al., 2008; Gerbaix et al., 2013; La Favor 
et al., 2013). In contrast to the previously mentioned studies, the results of the current study 
suggest that an exercise intervention for 9 weeks did not modify the blood lipid profile of the 
dyslipidaemic rats. This discrepancy can be explained by the fact that both De Moraes et al 
(2008) and La Favor et al (2013) reported decreased blood lipids in conjunction with 
decreases of body weight. Indeed, previous human studies have reported that a decrease in 
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blood lipid concentration is more likely to occur in conjunction with weight loss (Coghill et al., 
2008; Roussel et al., 2009; Yoshida et al., 2010). In my study, the animals did not lose body 
weight in response to exercise which may explain the absence of improvement of blood 
lipids. However the rats in the current study did not have an increased body weight 
regardless of diet. Hence it is unlikely that they will lose even more weight. The findings from 
several exercise studies in rats consuming a high fat diet were in agreement with our 
findings that exercise training did not change the elevated blood lipids (Cambri et al., 2011; 
Teixeira de Lemos et al., 2011; Delghingaro-Augusto et al., 2012). Similarly, previous 
studies in humans did not record improvement of blood lipids following exercise (Arsenault et 
al., 2009; Lima et al., 2012). Thus, the findings from the current study suggest that exercise 
for 9 weeks; despite a low body weight did not ameliorate dyslipidaemia induced by HFHS 
diet consumption.  
 
5.4.4 Exercise and blood pressure 
Exercise training is known to decrease BP in humans, especially in individuals with a high 
baseline BP (Coghill et al., 2008; Roussel et al., 2009). Moreover, in individuals with 
dyslipidaemia exercise training results in a decreased BP when accompanied by a decrease 
in blood lipids and body weight (Stewart et al., 2005; Drevenhorn et al., 2007; Coghill et al., 
2008; Roussel et al., 2009). In contrast to these findings in the current study, exercise did 
not alter the elevated blood pressure induced by consumption of the HFHS diet. The 
discrepancy may be explained by the fact that exercise did not induce weight loss and did 
not decrease blood lipids; therefore exercise did not improve the elevated blood pressure 
induced by HFHS diet consumption. Similarly, a previous study in rats fed a HFHS diet 
showed no change in BP in the absence of a change in lipids and body weight after exercise 
training (Paulino et al., 2010). Moreover, several human studies reported similar results 
whereby blood pressure was unchanged (Watkins et al., 2003; Green et al., 2003; Camhi et 
al., 2010). These observations suggest that exercise for 9 consecutive weeks without loss of 
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body weight and without decrease of blood lipid did not improve the elevated blood pressure 
induced by HFHS diet consumption. 
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Chapter Six: Conclusion 
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6.1 Conclusion 
The current study investigated the effect of 9 weeks of HFHS diet consumption and exercise 
on 3-month-old rats. The metabolic and cardiovascular parameters investigated were blood 
glucose, insulin concentration, glycated haemoglobin, fasting and non- fasting blood lipids, 
hepatic glycogen and lipid content as well as blood pressure, vascular reactivity and heart 
dimensions and functions. Findings of the current study showed that 9 weeks of HFHS diet 
consumption had induced dyslipidaemia and increased liver glycogen content and that was 
without inducing obesity in these animals. While HFHS diet did not induce obesity, it also did 
not induce an increase in adipose tissue or organ weight. Furthermore, dyslipidaemia was 
not associated with other metabolic disturbances such as hyperglycaemia, insulin resistance 
or a change in the hepatic lipid content. In addition to the metabolic changes, short-term 
HFHS diet consumption resulted in elevated blood pressure in non-obese animals. There 
were no changes in heart dimension and function as well as vascular reactivity associated 
with the high blood pressure during the time of the study. These observations suggest that 
HFHS diet consumption for 9 weeks induced elevated BP without inducing the complications 
associated with hypertension. We can conclude from the current study that short-term 
consumption of HFHS diet induced dyslipidaemia and elevated hepatic glycogen content in 
non-obese animals without further metabolic disturbances. Additionally, HFHS diet induced 
elevated blood pressure in non-obese animals without further impact on vascular reactivity 
and wall thickness. The elevation in BP may be linked directly to the increased in blood lipids 
concentration.  
Additionally, the current study evaluated the impact of 9 weeks of exercise on the metabolic 
and cardiovascular changes induced by the short term HFHS diet. Indeed, exercise for 9 
weeks without weight loss did not ameliorate dyslipidaemia or the high hepatic glycogen 
content in the animals consuming the HFHS diet. In addition exercise did not change the 
adipose tissue weight, blood glucose, glycated HbA1c or insulin concentrations in both 
dietary interventions. Moreover, exercise did not change the bone length or bone density or 
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organs weight. Furthermore, exercise did not drop the elevated blood pressure and did not 
induce changes in the heart function and dimensions or vascular reactivity. Hence exercise 
alone is not effective in combatting the adverse effects of a HFHS diet.  
 
6.2 Limitations and future studies 
The possible limitations of the current study are as follow: firstly, the most important 
limitation is the lack of recommended vitamins and minerals in the diet compositions. The 
vitamins and minerals are essential micro-compositions required for the animal’s wellbeing, 
general health and growth. In this regard, in future studies an additional group is suggested 
to be added for better comparison between the animals’ growth in rats consuming the HFHS 
diet with or without essential vitamins and minerals. Secondly, the aim of this study was to 
investigate the effect of a HFHS diet for a short duration. However, a HFHS diet 
administration for longer duration may have resulted in more adverse outcomes. Therefore, 
the effect of a long duration dietary intervention need to be further investigated to compare 
the findings from the current study to the impact of chronic consumption of HFHS diet. 
Thirdly, the present study investigated the effects of a HFHS diet and exercise in males only. 
Future studies needs to include female rats to compare diet and exercise effect in both 
genders. Fourthly, the mechanism responsible for the concurrent development of 
dyslipidaemia and high blood pressure needs further investigation, as neither inflammatory 
markers, quantitative measurements of oxidative stress substances or molecular technology 
were measured in this study. Additionally, low room temperature in the animal unit is another 
limitation to be considered, because at higher temperature an increased body weight and 
hence an altered glucose metabolism may have been observed. Another limitation in the 
current study is that we did not measure the liver enzymes. Therefore, we could not 
investigate the effect of HFHS diet on the liver functions. On the other hand, further studies 
need to include a high fat diet group and a high sucrose diet group to be investigate the 
effects of each component independently and to compare it to the HFHS diet effects. 
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Furthermore, the current study did not investigate the effect of exercise on the musculature 
which has an important role in insulin sensitivity and glycogen storage capacity. Therefore, 
the effect of a HFHS diet and exercise in the muscle need to be investigated. In addition to 
the previously mentioned limitations, all the selected rats were runners and exercised 
voluntarily. Therefore, the effect of exercise needs to be investigated in the runners 
compared to non-runners animals to eliminate the effect of the period of exercise in the non-
exercising group. Finally, the exercise intervention in dyslipidemic animals did not ameliorate 
the dyslipidaemia and blood pressure. Further studies are needed with different interventions 
to elucidate this finding. 
 
6.3 Uniqueness and strength of current study  
The uniqueness of current project is in studying the effect of HFHS diet without the 
confounding effect of obesity and its associated disturbances. In non-obese animals, a 
HFHS diet elevated liver glycogen content, induced dyslipidaemia and elevated blood 
pressure. Additionally, this study investigated the impact of exercise on the metabolic and 
cardiovascular disturbances induced by HFHS diet consumption without the confounding 
effect of weight loss.  In this regard to my knowledge there are limited studies that 
investigated the effect of exercise in a HFHS diet model and that have evaluated the effect 
of exercise in non-obese animals without the confounding effect of weight loss.  
The study design of this research where there was a control group for each interventional 
variable, made it possible to evaluate the effect of each variable independently. While the 
standard diet groups acted as a control for the HFHS diet groups, the sedentary groups 
served as a control for the exercising groups. 
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6.4 Possible clinical implications and recommendations 
The findings from this study could be translated to humans.  In this regard the HFHS diet 
model imitated the consumed western diet. The short-term HFHS diet intervention induced 
elevated liver glycogen content, dyslipidaemia and elevated blood pressure in non-obese 
animals. These findings suggest that a western diet for even a short period of time can 
predispose lean individuals to metabolic and cardiovascular disturbances. Therefore, public 
education and awareness about the side effects of a western diet and the encouragement of 
healthy eating habits should take priority.  
In the current study an exercise intervention did not ameliorate the metabolic and 
cardiovascular changes induced by the HFHS diet in non-obese animals. Therefore it can be 
suggested that exercise training alone may not be sufficient in counteracting the negative 
effects of a western diet, even in lean individuals. More aggressive management such as an 
intense lifestyle intervention or pharmacological therapy may be suggested in lean 
individuals with the elevated blood pressure associated with dyslipidaemia.  
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